CN115011609B - BnaFANCM gene, application and method for obtaining male sterile mutant of rape - Google Patents
BnaFANCM gene, application and method for obtaining male sterile mutant of rape Download PDFInfo
- Publication number
- CN115011609B CN115011609B CN202210631019.0A CN202210631019A CN115011609B CN 115011609 B CN115011609 B CN 115011609B CN 202210631019 A CN202210631019 A CN 202210631019A CN 115011609 B CN115011609 B CN 115011609B
- Authority
- CN
- China
- Prior art keywords
- bnafancm
- gene
- ser
- lys
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 40
- 108091033409 CRISPR Proteins 0.000 claims abstract description 39
- 239000013598 vector Substances 0.000 claims abstract description 32
- 241000196324 Embryophyta Species 0.000 claims abstract description 25
- 238000010362 genome editing Methods 0.000 claims abstract description 19
- 108091027544 Subgenomic mRNA Proteins 0.000 claims abstract description 12
- 230000009261 transgenic effect Effects 0.000 claims abstract description 12
- 239000002773 nucleotide Substances 0.000 claims description 19
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- 240000002791 Brassica napus Species 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 18
- 235000011293 Brassica napus Nutrition 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 13
- 241000589158 Agrobacterium Species 0.000 claims description 12
- 238000009395 breeding Methods 0.000 claims description 7
- 230000001488 breeding effect Effects 0.000 claims description 7
- 230000037433 frameshift Effects 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 6
- 231100000221 frame shift mutation induction Toxicity 0.000 claims description 5
- 239000013612 plasmid Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 240000000220 Panda oleosa Species 0.000 claims description 4
- 235000016496 Panda oleosa Nutrition 0.000 claims description 4
- 108020004705 Codon Proteins 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 240000007124 Brassica oleracea Species 0.000 abstract description 10
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 abstract description 10
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 abstract description 10
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 abstract description 10
- 108700001094 Plant Genes Proteins 0.000 abstract description 2
- 238000003976 plant breeding Methods 0.000 abstract description 2
- 102100034552 Fanconi anemia group M protein Human genes 0.000 abstract 1
- 101000848187 Homo sapiens Fanconi anemia group M protein Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 25
- 239000000203 mixture Substances 0.000 description 22
- 239000007788 liquid Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 15
- 239000002609 medium Substances 0.000 description 13
- 239000000499 gel Substances 0.000 description 12
- 239000001963 growth medium Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 9
- 230000035772 mutation Effects 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 101150090685 Fancm gene Proteins 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108020005004 Guide RNA Proteins 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 239000000701 coagulant Substances 0.000 description 5
- 108010015792 glycyllysine Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 241000880493 Leptailurus serval Species 0.000 description 4
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 108010062796 arginyllysine Proteins 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000012257 pre-denaturation Methods 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 108010061238 threonyl-glycine Proteins 0.000 description 4
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 4
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 3
- 206010021929 Infertility male Diseases 0.000 description 3
- 208000007466 Male Infertility Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 3
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 3
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 3
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 108010054155 lysyllysine Proteins 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 229940027257 timentin Drugs 0.000 description 3
- 108010073969 valyllysine Proteins 0.000 description 3
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 2
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 2
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 2
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 2
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 2
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 2
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 2
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 2
- FBLMOFHNVQBKRR-IHRRRGAJSA-N Arg-Asp-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FBLMOFHNVQBKRR-IHRRRGAJSA-N 0.000 description 2
- CPTXATAOUQJQRO-GUBZILKMSA-N Arg-Val-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O CPTXATAOUQJQRO-GUBZILKMSA-N 0.000 description 2
- COWITDLVHMZSIW-CIUDSAMLSA-N Asn-Lys-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O COWITDLVHMZSIW-CIUDSAMLSA-N 0.000 description 2
- MYTHOBCLNIOFBL-SRVKXCTJSA-N Asn-Ser-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYTHOBCLNIOFBL-SRVKXCTJSA-N 0.000 description 2
- AMGQTNHANMRPOE-LKXGYXEUSA-N Asn-Thr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O AMGQTNHANMRPOE-LKXGYXEUSA-N 0.000 description 2
- XACXDSRQIXRMNS-OLHMAJIHSA-N Asp-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)O XACXDSRQIXRMNS-OLHMAJIHSA-N 0.000 description 2
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 2
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 2
- BPAUXFVCSYQDQX-JRQIVUDYSA-N Asp-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)N)O BPAUXFVCSYQDQX-JRQIVUDYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PRXCTTWKGJAPMT-ZLUOBGJFSA-N Cys-Ala-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O PRXCTTWKGJAPMT-ZLUOBGJFSA-N 0.000 description 2
- VNXXMHTZQGGDSG-CIUDSAMLSA-N Cys-His-Asn Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O VNXXMHTZQGGDSG-CIUDSAMLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 2
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 2
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 2
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 2
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 2
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 2
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 2
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 2
- ZKJZBRHRWKLVSJ-ZDLURKLDSA-N Gly-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)O ZKJZBRHRWKLVSJ-ZDLURKLDSA-N 0.000 description 2
- MWAJSVTZZOUOBU-IHRRRGAJSA-N His-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CN=CN1 MWAJSVTZZOUOBU-IHRRRGAJSA-N 0.000 description 2
- FBVHRDXSCYELMI-PBCZWWQYSA-N His-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O FBVHRDXSCYELMI-PBCZWWQYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 2
- MPOHDJKRBLVGCT-CIUDSAMLSA-N Lys-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N MPOHDJKRBLVGCT-CIUDSAMLSA-N 0.000 description 2
- WXJKFRMKJORORD-DCAQKATOSA-N Lys-Arg-Ala Chemical compound NC(=N)NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CCCCN WXJKFRMKJORORD-DCAQKATOSA-N 0.000 description 2
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 2
- ABHIXYDMILIUKV-CIUDSAMLSA-N Lys-Asn-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ABHIXYDMILIUKV-CIUDSAMLSA-N 0.000 description 2
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 2
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 2
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 2
- PLOUVAYOMTYJRG-JXUBOQSCSA-N Lys-Thr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PLOUVAYOMTYJRG-JXUBOQSCSA-N 0.000 description 2
- RYOLKFYZBHMYFW-WDSOQIARSA-N Lys-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 RYOLKFYZBHMYFW-WDSOQIARSA-N 0.000 description 2
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- QAHFGYLFLVGBNW-DCAQKATOSA-N Met-Ala-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN QAHFGYLFLVGBNW-DCAQKATOSA-N 0.000 description 2
- OLWAOWXIADGIJG-AVGNSLFASA-N Met-Arg-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(O)=O OLWAOWXIADGIJG-AVGNSLFASA-N 0.000 description 2
- BMHIFARYXOJDLD-WPRPVWTQSA-N Met-Gly-Val Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O BMHIFARYXOJDLD-WPRPVWTQSA-N 0.000 description 2
- 108010047562 NGR peptide Proteins 0.000 description 2
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 2
- QFBNNYNWKYKVJO-DCAQKATOSA-N Ser-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N QFBNNYNWKYKVJO-DCAQKATOSA-N 0.000 description 2
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 2
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 2
- KCFKKAQKRZBWJB-ZLUOBGJFSA-N Ser-Cys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O KCFKKAQKRZBWJB-ZLUOBGJFSA-N 0.000 description 2
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 2
- QJKPECIAWNNKIT-KKUMJFAQSA-N Ser-Lys-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QJKPECIAWNNKIT-KKUMJFAQSA-N 0.000 description 2
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 2
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 2
- XPVIVVLLLOFBRH-XIRDDKMYSA-N Ser-Trp-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(O)=O XPVIVVLLLOFBRH-XIRDDKMYSA-N 0.000 description 2
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 2
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 2
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 2
- MMTOHPRBJKEZHT-BWBBJGPYSA-N Thr-Cys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O MMTOHPRBJKEZHT-BWBBJGPYSA-N 0.000 description 2
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 2
- KRDSCBLRHORMRK-JXUBOQSCSA-N Thr-Lys-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O KRDSCBLRHORMRK-JXUBOQSCSA-N 0.000 description 2
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 2
- GITNQBVCEQBDQC-KKUMJFAQSA-N Tyr-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O GITNQBVCEQBDQC-KKUMJFAQSA-N 0.000 description 2
- WOCYUGQDXPTQPY-FXQIFTODSA-N Val-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N WOCYUGQDXPTQPY-FXQIFTODSA-N 0.000 description 2
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 2
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 2
- CHWRZUGUMAMTFC-IHRRRGAJSA-N Val-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CNC=N1 CHWRZUGUMAMTFC-IHRRRGAJSA-N 0.000 description 2
- MBGFDZDWMDLXHQ-GUBZILKMSA-N Val-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C(C)C)N MBGFDZDWMDLXHQ-GUBZILKMSA-N 0.000 description 2
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 2
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 2
- PQSNETRGCRUOGP-KKHAAJSZSA-N Val-Thr-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O PQSNETRGCRUOGP-KKHAAJSZSA-N 0.000 description 2
- ODUHAIXFXFACDY-SRVKXCTJSA-N Val-Val-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)C(C)C ODUHAIXFXFACDY-SRVKXCTJSA-N 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 108010036533 arginylvaline Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 101150038500 cas9 gene Proteins 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 108010045397 lysyl-tyrosyl-lysine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000011317 telomere syndrome Diseases 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 108010000998 wheylin-2 peptide Proteins 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- ODWSTKXGQGYHSH-FXQIFTODSA-N Ala-Arg-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O ODWSTKXGQGYHSH-FXQIFTODSA-N 0.000 description 1
- GORKKVHIBWAQHM-GCJQMDKQSA-N Ala-Asn-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GORKKVHIBWAQHM-GCJQMDKQSA-N 0.000 description 1
- ZIBWKCRKNFYTPT-ZKWXMUAHSA-N Ala-Asn-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZIBWKCRKNFYTPT-ZKWXMUAHSA-N 0.000 description 1
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 1
- XAGIMRPOEJSYER-CIUDSAMLSA-N Ala-Cys-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N XAGIMRPOEJSYER-CIUDSAMLSA-N 0.000 description 1
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- XCIGOVDXZULBBV-DCAQKATOSA-N Ala-Val-Lys Chemical compound CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(O)=O XCIGOVDXZULBBV-DCAQKATOSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 108700029019 Arabidopsis FANCM Proteins 0.000 description 1
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 1
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 1
- XPSGESXVBSQZPL-SRVKXCTJSA-N Arg-Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XPSGESXVBSQZPL-SRVKXCTJSA-N 0.000 description 1
- NONSEUUPKITYQT-BQBZGAKWSA-N Arg-Asn-Gly Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N)CN=C(N)N NONSEUUPKITYQT-BQBZGAKWSA-N 0.000 description 1
- IIABBYGHLYWVOS-FXQIFTODSA-N Arg-Asn-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O IIABBYGHLYWVOS-FXQIFTODSA-N 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- SQKPKIJVWHAWNF-DCAQKATOSA-N Arg-Asp-Lys Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O SQKPKIJVWHAWNF-DCAQKATOSA-N 0.000 description 1
- RRGPUNYIPJXJBU-GUBZILKMSA-N Arg-Asp-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O RRGPUNYIPJXJBU-GUBZILKMSA-N 0.000 description 1
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- GITAWLWBTMJPKH-AVGNSLFASA-N Arg-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GITAWLWBTMJPKH-AVGNSLFASA-N 0.000 description 1
- JCROZIFVIYMXHM-GUBZILKMSA-N Arg-Met-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N JCROZIFVIYMXHM-GUBZILKMSA-N 0.000 description 1
- KSUALAGYYLQSHJ-RCWTZXSCSA-N Arg-Met-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KSUALAGYYLQSHJ-RCWTZXSCSA-N 0.000 description 1
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 1
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 1
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 1
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 1
- LRPZJPMQGKGHSG-XGEHTFHBSA-N Arg-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)O LRPZJPMQGKGHSG-XGEHTFHBSA-N 0.000 description 1
- INOIAEUXVVNJKA-XGEHTFHBSA-N Arg-Thr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O INOIAEUXVVNJKA-XGEHTFHBSA-N 0.000 description 1
- UGJLILSJKSBVIR-ZFWWWQNUSA-N Arg-Trp-Gly Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(O)=O)=CNC2=C1 UGJLILSJKSBVIR-ZFWWWQNUSA-N 0.000 description 1
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 1
- XHFXZQHTLJVZBN-FXQIFTODSA-N Asn-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N XHFXZQHTLJVZBN-FXQIFTODSA-N 0.000 description 1
- GXMSVVBIAMWMKO-BQBZGAKWSA-N Asn-Arg-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N GXMSVVBIAMWMKO-BQBZGAKWSA-N 0.000 description 1
- PCKRJVZAQZWNKM-WHFBIAKZSA-N Asn-Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O PCKRJVZAQZWNKM-WHFBIAKZSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- SPIPSJXLZVTXJL-ZLUOBGJFSA-N Asn-Cys-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O SPIPSJXLZVTXJL-ZLUOBGJFSA-N 0.000 description 1
- CTQIOCMSIJATNX-WHFBIAKZSA-N Asn-Gly-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O CTQIOCMSIJATNX-WHFBIAKZSA-N 0.000 description 1
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 1
- AITGTTNYKAWKDR-CIUDSAMLSA-N Asn-His-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O AITGTTNYKAWKDR-CIUDSAMLSA-N 0.000 description 1
- FTSAJSADJCMDHH-CIUDSAMLSA-N Asn-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N FTSAJSADJCMDHH-CIUDSAMLSA-N 0.000 description 1
- REQUGIWGOGSOEZ-ZLUOBGJFSA-N Asn-Ser-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N REQUGIWGOGSOEZ-ZLUOBGJFSA-N 0.000 description 1
- KYQJHBWHRASMKG-ZLUOBGJFSA-N Asn-Ser-Cys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O KYQJHBWHRASMKG-ZLUOBGJFSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 1
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 1
- DPWDPEVGACCWTC-SRVKXCTJSA-N Asn-Tyr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O DPWDPEVGACCWTC-SRVKXCTJSA-N 0.000 description 1
- ZAESWDKAMDVHLL-RCOVLWMOSA-N Asn-Val-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O ZAESWDKAMDVHLL-RCOVLWMOSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- GBAWQWASNGUNQF-ZLUOBGJFSA-N Asp-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N GBAWQWASNGUNQF-ZLUOBGJFSA-N 0.000 description 1
- SLHOOKXYTYAJGQ-XVYDVKMFSA-N Asp-Ala-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 SLHOOKXYTYAJGQ-XVYDVKMFSA-N 0.000 description 1
- CXBOKJPLEYUPGB-FXQIFTODSA-N Asp-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N CXBOKJPLEYUPGB-FXQIFTODSA-N 0.000 description 1
- NJIKKGUVGUBICV-ZLUOBGJFSA-N Asp-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O NJIKKGUVGUBICV-ZLUOBGJFSA-N 0.000 description 1
- ZLGKHJHFYSRUBH-FXQIFTODSA-N Asp-Arg-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLGKHJHFYSRUBH-FXQIFTODSA-N 0.000 description 1
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 1
- NAPNAGZWHQHZLG-ZLUOBGJFSA-N Asp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N NAPNAGZWHQHZLG-ZLUOBGJFSA-N 0.000 description 1
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 1
- AKPLMZMNJGNUKT-ZLUOBGJFSA-N Asp-Asp-Cys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O AKPLMZMNJGNUKT-ZLUOBGJFSA-N 0.000 description 1
- BFOYULZBKYOKAN-OLHMAJIHSA-N Asp-Asp-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFOYULZBKYOKAN-OLHMAJIHSA-N 0.000 description 1
- AMRANMVXQWXNAH-ZLUOBGJFSA-N Asp-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(O)=O AMRANMVXQWXNAH-ZLUOBGJFSA-N 0.000 description 1
- MJKBOVWWADWLHV-ZLUOBGJFSA-N Asp-Cys-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)C(=O)O MJKBOVWWADWLHV-ZLUOBGJFSA-N 0.000 description 1
- NURJSGZGBVJFAD-ZLUOBGJFSA-N Asp-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)C(=O)O NURJSGZGBVJFAD-ZLUOBGJFSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 1
- OGTCOKZFOJIZFG-CIUDSAMLSA-N Asp-His-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O OGTCOKZFOJIZFG-CIUDSAMLSA-N 0.000 description 1
- ODNWIBOCFGMRTP-SRVKXCTJSA-N Asp-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CN=CN1 ODNWIBOCFGMRTP-SRVKXCTJSA-N 0.000 description 1
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 1
- WWOYXVBGHAHQBG-FXQIFTODSA-N Asp-Met-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O WWOYXVBGHAHQBG-FXQIFTODSA-N 0.000 description 1
- FIAKNCXQFFKSSI-ZLUOBGJFSA-N Asp-Ser-Cys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O FIAKNCXQFFKSSI-ZLUOBGJFSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
- AEJSNWMRPXAKCW-WHFBIAKZSA-N Cys-Ala-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AEJSNWMRPXAKCW-WHFBIAKZSA-N 0.000 description 1
- CPTUXCUWQIBZIF-ZLUOBGJFSA-N Cys-Asn-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CPTUXCUWQIBZIF-ZLUOBGJFSA-N 0.000 description 1
- OXOQBEVULIBOSH-ZDLURKLDSA-N Cys-Gly-Thr Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O OXOQBEVULIBOSH-ZDLURKLDSA-N 0.000 description 1
- KGIHMGPYGXBYJJ-SRVKXCTJSA-N Cys-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS KGIHMGPYGXBYJJ-SRVKXCTJSA-N 0.000 description 1
- MQQLYEHXSBJTRK-FXQIFTODSA-N Cys-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N MQQLYEHXSBJTRK-FXQIFTODSA-N 0.000 description 1
- AZDQAZRURQMSQD-XPUUQOCRSA-N Cys-Val-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AZDQAZRURQMSQD-XPUUQOCRSA-N 0.000 description 1
- 201000004939 Fanconi anemia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 1
- KFMBRBPXHVMDFN-UWVGGRQHSA-N Gly-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCNC(N)=N KFMBRBPXHVMDFN-UWVGGRQHSA-N 0.000 description 1
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 1
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 1
- SUDUYJOBLHQAMI-WHFBIAKZSA-N Gly-Asp-Cys Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O SUDUYJOBLHQAMI-WHFBIAKZSA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 1
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
- OMOZPGCHVWOXHN-BQBZGAKWSA-N Gly-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN OMOZPGCHVWOXHN-BQBZGAKWSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 1
- BXDLTKLPPKBVEL-FJXKBIBVSA-N Gly-Thr-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O BXDLTKLPPKBVEL-FJXKBIBVSA-N 0.000 description 1
- UMBDRSMLCUYIRI-DVJZZOLTSA-N Gly-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN)O UMBDRSMLCUYIRI-DVJZZOLTSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- SVHKVHBPTOMLTO-DCAQKATOSA-N His-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SVHKVHBPTOMLTO-DCAQKATOSA-N 0.000 description 1
- MIHTTYXBXIRRGV-AVGNSLFASA-N His-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N MIHTTYXBXIRRGV-AVGNSLFASA-N 0.000 description 1
- FHKZHRMERJUXRJ-DCAQKATOSA-N His-Ser-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 FHKZHRMERJUXRJ-DCAQKATOSA-N 0.000 description 1
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 1
- XHQYFGPIRUHQIB-PBCZWWQYSA-N His-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CN=CN1 XHQYFGPIRUHQIB-PBCZWWQYSA-N 0.000 description 1
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 1
- NBWATNYAUVSAEQ-ZEILLAHLSA-N His-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O NBWATNYAUVSAEQ-ZEILLAHLSA-N 0.000 description 1
- RNVUQLOKVIPNEM-BZSNNMDCSA-N His-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O RNVUQLOKVIPNEM-BZSNNMDCSA-N 0.000 description 1
- PUFNQIPSRXVLQJ-IHRRRGAJSA-N His-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N PUFNQIPSRXVLQJ-IHRRRGAJSA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- BTSXLXFPMZXVPR-DLOVCJGASA-N Lys-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BTSXLXFPMZXVPR-DLOVCJGASA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- BRSGXFITDXFMFF-IHRRRGAJSA-N Lys-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N BRSGXFITDXFMFF-IHRRRGAJSA-N 0.000 description 1
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- FLCMXEFCTLXBTL-DCAQKATOSA-N Lys-Asp-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N FLCMXEFCTLXBTL-DCAQKATOSA-N 0.000 description 1
- PHHYNOUOUWYQRO-XIRDDKMYSA-N Lys-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N PHHYNOUOUWYQRO-XIRDDKMYSA-N 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- VLMNBMFYRMGEMB-QWRGUYRKSA-N Lys-His-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 VLMNBMFYRMGEMB-QWRGUYRKSA-N 0.000 description 1
- YXTKSLRSRXKXNV-IHRRRGAJSA-N Lys-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N YXTKSLRSRXKXNV-IHRRRGAJSA-N 0.000 description 1
- HQXSFFSLXFHWOX-IXOXFDKPSA-N Lys-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N)O HQXSFFSLXFHWOX-IXOXFDKPSA-N 0.000 description 1
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 1
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 1
- URBJRJKWSUFCKS-AVGNSLFASA-N Lys-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCCN)N URBJRJKWSUFCKS-AVGNSLFASA-N 0.000 description 1
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 1
- ZUGVARDEGWMMLK-SRVKXCTJSA-N Lys-Ser-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN ZUGVARDEGWMMLK-SRVKXCTJSA-N 0.000 description 1
- YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 1
- WAAZECNCPVGPIV-RHYQMDGZSA-N Lys-Thr-Met Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O WAAZECNCPVGPIV-RHYQMDGZSA-N 0.000 description 1
- JMENHIOOENGKIL-JGFWFPDNSA-N Lys-Thr-Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@H](O)C)C(O)=O)C1=CC=C(O)C=C1 JMENHIOOENGKIL-JGFWFPDNSA-N 0.000 description 1
- VWPJQIHBBOJWDN-DCAQKATOSA-N Lys-Val-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O VWPJQIHBBOJWDN-DCAQKATOSA-N 0.000 description 1
- BWECSLVQIWEMSC-IHRRRGAJSA-N Lys-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BWECSLVQIWEMSC-IHRRRGAJSA-N 0.000 description 1
- AHZNUGRZHMZGFL-GUBZILKMSA-N Met-Arg-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCNC(N)=N AHZNUGRZHMZGFL-GUBZILKMSA-N 0.000 description 1
- CAODKDAPYGUMLK-FXQIFTODSA-N Met-Asn-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CAODKDAPYGUMLK-FXQIFTODSA-N 0.000 description 1
- OHMKUHXCDSCOMT-QXEWZRGKSA-N Met-Asn-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O OHMKUHXCDSCOMT-QXEWZRGKSA-N 0.000 description 1
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 1
- SCKPOOMCTFEVTN-QTKMDUPCSA-N Met-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCSC)N)O SCKPOOMCTFEVTN-QTKMDUPCSA-N 0.000 description 1
- XMQZLGBUJMMODC-AVGNSLFASA-N Met-His-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O XMQZLGBUJMMODC-AVGNSLFASA-N 0.000 description 1
- AXHNAGAYRGCDLG-UWVGGRQHSA-N Met-Lys-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AXHNAGAYRGCDLG-UWVGGRQHSA-N 0.000 description 1
- IHRFZLQEQVHXFA-RHYQMDGZSA-N Met-Thr-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCCN IHRFZLQEQVHXFA-RHYQMDGZSA-N 0.000 description 1
- UZBQXELAFPCGRV-SZMVWBNQSA-N Met-Trp-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZBQXELAFPCGRV-SZMVWBNQSA-N 0.000 description 1
- OVTOTTGZBWXLFU-QXEWZRGKSA-N Met-Val-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O OVTOTTGZBWXLFU-QXEWZRGKSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- DWUIECHTAMYEFL-XVYDVKMFSA-N Ser-Ala-His Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DWUIECHTAMYEFL-XVYDVKMFSA-N 0.000 description 1
- HBZBPFLJNDXRAY-FXQIFTODSA-N Ser-Ala-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O HBZBPFLJNDXRAY-FXQIFTODSA-N 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 1
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 1
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 1
- TYYBJUYSTWJHGO-ZKWXMUAHSA-N Ser-Asn-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TYYBJUYSTWJHGO-ZKWXMUAHSA-N 0.000 description 1
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 1
- HEQPKICPPDOSIN-SRVKXCTJSA-N Ser-Asp-Tyr Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HEQPKICPPDOSIN-SRVKXCTJSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- QGAHMVHBORDHDC-YUMQZZPRSA-N Ser-His-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 QGAHMVHBORDHDC-YUMQZZPRSA-N 0.000 description 1
- HZNFKPJCGZXKIC-DCAQKATOSA-N Ser-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N HZNFKPJCGZXKIC-DCAQKATOSA-N 0.000 description 1
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- SRKMDKACHDVPMD-SRVKXCTJSA-N Ser-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N SRKMDKACHDVPMD-SRVKXCTJSA-N 0.000 description 1
- OCWWJBZQXGYQCA-DCAQKATOSA-N Ser-Lys-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O OCWWJBZQXGYQCA-DCAQKATOSA-N 0.000 description 1
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 1
- VIIJCAQMJBHSJH-FXQIFTODSA-N Ser-Met-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O VIIJCAQMJBHSJH-FXQIFTODSA-N 0.000 description 1
- RXSWQCATLWVDLI-XGEHTFHBSA-N Ser-Met-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RXSWQCATLWVDLI-XGEHTFHBSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- QNBVFKZSSRYNFX-CUJWVEQBSA-N Ser-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N)O QNBVFKZSSRYNFX-CUJWVEQBSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 1
- HXPNJVLVHKABMJ-KKUMJFAQSA-N Ser-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CO)N)O HXPNJVLVHKABMJ-KKUMJFAQSA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- IAOHCSQDQDWRQU-GUBZILKMSA-N Ser-Val-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IAOHCSQDQDWRQU-GUBZILKMSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- YRNBANYVJJBGDI-VZFHVOOUSA-N Thr-Ala-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)N)O YRNBANYVJJBGDI-VZFHVOOUSA-N 0.000 description 1
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 1
- JTEICXDKGWKRRV-HJGDQZAQSA-N Thr-Asn-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O JTEICXDKGWKRRV-HJGDQZAQSA-N 0.000 description 1
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
- VXMHQKHDKCATDV-VEVYYDQMSA-N Thr-Asp-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VXMHQKHDKCATDV-VEVYYDQMSA-N 0.000 description 1
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 1
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 1
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 1
- NQVDGKYAUHTCME-QTKMDUPCSA-N Thr-His-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O NQVDGKYAUHTCME-QTKMDUPCSA-N 0.000 description 1
- HEJJDUDEHLPDAW-CUJWVEQBSA-N Thr-His-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CS)C(=O)O)N)O HEJJDUDEHLPDAW-CUJWVEQBSA-N 0.000 description 1
- TZJSEJOXAIWOST-RHYQMDGZSA-N Thr-Lys-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N TZJSEJOXAIWOST-RHYQMDGZSA-N 0.000 description 1
- ZSPQUTWLWGWTPS-HJGDQZAQSA-N Thr-Lys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZSPQUTWLWGWTPS-HJGDQZAQSA-N 0.000 description 1
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 1
- MGJLBZFUXUGMML-VOAKCMCISA-N Thr-Lys-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MGJLBZFUXUGMML-VOAKCMCISA-N 0.000 description 1
- YJVJPJPHHFOVMG-VEVYYDQMSA-N Thr-Met-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O YJVJPJPHHFOVMG-VEVYYDQMSA-N 0.000 description 1
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 1
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- NDLHSJWPCXKOGG-VLCNGCBASA-N Thr-Trp-Tyr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N)O NDLHSJWPCXKOGG-VLCNGCBASA-N 0.000 description 1
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 1
- BRBCKMMXKONBAA-KWBADKCTSA-N Trp-Ala-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 BRBCKMMXKONBAA-KWBADKCTSA-N 0.000 description 1
- ICNFHVUVCNWUAB-SZMVWBNQSA-N Trp-Arg-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ICNFHVUVCNWUAB-SZMVWBNQSA-N 0.000 description 1
- HQJOVVWAPQPYDS-ZFWWWQNUSA-N Trp-Gly-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O HQJOVVWAPQPYDS-ZFWWWQNUSA-N 0.000 description 1
- UPOGHWJJZAZNSW-XIRDDKMYSA-N Trp-His-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O UPOGHWJJZAZNSW-XIRDDKMYSA-N 0.000 description 1
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 1
- NSTPFWRAIDTNGH-BZSNNMDCSA-N Tyr-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NSTPFWRAIDTNGH-BZSNNMDCSA-N 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- QOEZFICGUZTRFX-IHRRRGAJSA-N Tyr-Cys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O QOEZFICGUZTRFX-IHRRRGAJSA-N 0.000 description 1
- HSBZWINKRYZCSQ-KKUMJFAQSA-N Tyr-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O HSBZWINKRYZCSQ-KKUMJFAQSA-N 0.000 description 1
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 1
- PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
- NKMFRGPKTIEXSK-ULQDDVLXSA-N Tyr-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NKMFRGPKTIEXSK-ULQDDVLXSA-N 0.000 description 1
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 1
- DJIJBQYBDKGDIS-JYJNAYRXSA-N Tyr-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O DJIJBQYBDKGDIS-JYJNAYRXSA-N 0.000 description 1
- REJBPZVUHYNMEN-LSJOCFKGSA-N Val-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N REJBPZVUHYNMEN-LSJOCFKGSA-N 0.000 description 1
- LABUITCFCAABSV-BPNCWPANSA-N Val-Ala-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LABUITCFCAABSV-BPNCWPANSA-N 0.000 description 1
- LABUITCFCAABSV-UHFFFAOYSA-N Val-Ala-Tyr Natural products CC(C)C(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LABUITCFCAABSV-UHFFFAOYSA-N 0.000 description 1
- NMANTMWGQZASQN-QXEWZRGKSA-N Val-Arg-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N NMANTMWGQZASQN-QXEWZRGKSA-N 0.000 description 1
- XPYNXORPPVTVQK-SRVKXCTJSA-N Val-Arg-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N XPYNXORPPVTVQK-SRVKXCTJSA-N 0.000 description 1
- WKWJJQZZZBBWKV-JYJNAYRXSA-N Val-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WKWJJQZZZBBWKV-JYJNAYRXSA-N 0.000 description 1
- BYOHPUZJVXWHAE-BYULHYEWSA-N Val-Asn-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BYOHPUZJVXWHAE-BYULHYEWSA-N 0.000 description 1
- DBOXBUDEAJVKRE-LSJOCFKGSA-N Val-Asn-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N DBOXBUDEAJVKRE-LSJOCFKGSA-N 0.000 description 1
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 1
- CGGVNFJRZJUVAE-BYULHYEWSA-N Val-Asp-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CGGVNFJRZJUVAE-BYULHYEWSA-N 0.000 description 1
- ZQGPWORGSNRQLN-NHCYSSNCSA-N Val-Asp-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZQGPWORGSNRQLN-NHCYSSNCSA-N 0.000 description 1
- YODDULVCGFQRFZ-ZKWXMUAHSA-N Val-Asp-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O YODDULVCGFQRFZ-ZKWXMUAHSA-N 0.000 description 1
- CJDZKZFMAXGUOJ-IHRRRGAJSA-N Val-Cys-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N CJDZKZFMAXGUOJ-IHRRRGAJSA-N 0.000 description 1
- XJFXZQKJQGYFMM-GUBZILKMSA-N Val-Cys-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)O)N XJFXZQKJQGYFMM-GUBZILKMSA-N 0.000 description 1
- JTWIMNMUYLQNPI-WPRPVWTQSA-N Val-Gly-Arg Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N JTWIMNMUYLQNPI-WPRPVWTQSA-N 0.000 description 1
- SYOMXKPPFZRELL-ONGXEEELSA-N Val-Gly-Lys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N SYOMXKPPFZRELL-ONGXEEELSA-N 0.000 description 1
- JVYIGCARISMLMV-HOCLYGCPSA-N Val-Gly-Trp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N JVYIGCARISMLMV-HOCLYGCPSA-N 0.000 description 1
- XBRMBDFYOFARST-AVGNSLFASA-N Val-His-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N XBRMBDFYOFARST-AVGNSLFASA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- RLVTVHSDKHBFQP-ULQDDVLXSA-N Val-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 RLVTVHSDKHBFQP-ULQDDVLXSA-N 0.000 description 1
- RTJPAGFXOWEBAI-SRVKXCTJSA-N Val-Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RTJPAGFXOWEBAI-SRVKXCTJSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 108010006195 arginyl-glycyl-aspartyl-cysteine Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010066988 asparaginyl-alanyl-glycyl-alanine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 108010007375 seryl-seryl-seryl-arginine Proteins 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
- C12N15/8289—Male sterility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides BnaFANCM gene, application and a method for obtaining a male sterile mutant of rape, relating to the technical fields of plant gene editing and plant breeding; firstly, obtaining homologous sequences BnaFANCM-C05 and BnaFANCM-A05 of 2 FANCMs; target1 and Target2 of CRISPPR/Cas 9 are designed according to the sequence of BnaFANCM-C05 gene; then constructing recombinant vectors pKSE401-BnaFANCM-CRISPR of which Target1 and Target2 are respectively fused with sgRNA; GV3101 containing pKSE 401-BnafaFANCM-CRISPR vector infects rape to obtain transgenic plant. The invention utilizes CRISPR/Cas9 system to edit the BnaFANCM gene of the cabbage type rape so as to create new male sterile rape germplasm resources, which not only has wide application prospect in rape heterosis utilization, but also has wide application prospect in the aspect of new germplasm creation.
Description
Technical Field
The invention relates to BnaFANCM gene, application and a method for obtaining male sterile mutant of rape, belonging to the technical field of plant gene editing and plant breeding.
Background
Cabbage type rape (Brassica napus l.) belongs to the brassicaceae family, brassica, and is one of the most important oil crops in china. The original rape is produced in the Mediterranean region of Europe, the 20 th century of China is introduced from Japan, and the original rape is introduced from Europe later, because the planting history of the rape in China is only nearly one hundred years, the excellent and heterogeneous resource is lacking, the rape germplasm resource is an indispensable material basis for scientific research, variety improvement and industrial development, and the research on the excellent and heterogeneous resource is an important field for guaranteeing the continuous development of new varieties of crops and the sustainable development of agricultural production, and is also the core competitive embodiment of the country in the crop breeding field.
At present, a male sterile system for utilizing rape heterosis in China mainly surrounds a cytoplasmic male sterile system and a nuclear male sterile system, but the 2 systems have some defects in practical production and application; in recent years, new progress is continuously made in the field of male sterility research of rape in China, and development of some molecular markers, cloning and research of breeding related genes and research of male sterility cultivation of the rape are continuously promoted.
The FANCM gene is involved in normal homologous chromosomal crossover, mitotic recombination and fertility of meiotic cells, and in Arabidopsis FANCM (a homolog of the mammalian Fanconi anemia complement M) inhibits recombination.
In recent years, the CRISPR/Cas9 (Clustered regulularly interspaced short palindromic repeats and CRISPR associated) system is an emerging genetic engineering technology capable of efficiently and accurately editing genome, and no report on the improvement of a rape FANCM gene by utilizing the CRISPR/Cas9 system exists at present.
Disclosure of Invention
Aiming at some defects and shortcomings of the prior art, the invention provides a novel method for creating male sterile rape germplasm resources; the invention also utilizes CRISPR/Cas9 system to carry out site-directed mutagenesis on the BnaFANCM gene of the brassica napus, thus obtaining a male sterile transgenic plant.
In order to achieve the technical purpose, the invention adopts the following technical scheme:
the invention firstly provides a male sterility related gene BnaFANCM of rape, wherein the gene BnaFANCM comprises a gene BnaFANCM-C05 and a gene BnaFANCM-A05, the nucleotide sequence of the BnaFANCM-C05 is shown as SEQ.ID.NO.8, and the nucleotide sequence of the BnaFANCM-A05 is shown as SEQ.ID.NO. 9.
The invention also provides an application of the BnaFANCM gene in male sterile breeding of rape.
The invention also provides a gene editing vector pKSE401-BnafANCM-CRISPR, which comprises a CRISPR/Cas9 system sequence element group for the BnafANCM gene editing of brassica napus, wherein the system sequence comprises U6-26p-Target1-gRNA, U6-26p-Target2-gRNA, a Cas9 gene optimized according to codons and a resistance gene Kana.
The invention also provides a genetically engineered bacterium for BnaFANCM gene editing of brassica napus, which is obtained by transforming host bacterium GV3101 by using the gene editing vector pKSE401-BnaFANCM-CRISPR.
The invention firstly provides a method for obtaining male sterile mutants of brassica napus, which utilizes a CRISPR/Cas9 system to edit the BnaFANCM gene of brassica napus, and further comprises the following steps:
(1) Target1 and Target2 of sgRNA are designed and screened aiming at BnaFANCM gene sequences in brassica napus, the nucleotide sequence of the Target1 is shown as SEQ ID No.1, the nucleotide sequence of the Target2 is shown as SEQ ID No.2, and primers required for constructing vectors are synthesized.
(2) Constructing a double-target CRISPR/Cas9 gene editing vector: and 2 targets, namely Target1 and Target2, are respectively connected with the sgRNA sequence through PCR amplification and enzyme digestion, so that a double-Target gene editing vector pKSE401-BnaFANCM-CRISPR is constructed.
(3) Transforming agrobacterium with pKSE401-BnafANCM-CRISPR vector to obtain agrobacterium with gene editing expression vector pKSE401-BnafANCM-CRISPR;
(4) Transferring the pKSE401-BnaFANCM-CRISPR vector into a receptor material by using an agrobacterium transformation mode, and obtaining a transgenic plant through the steps of infection of rape hypocotyl, callus induction, redifferentiation, rooting culture and the like.
Further, in order to verify that the obtained plant is a target plant, positive seedling plants are screened from transgenic plants, amplification identification is carried out by utilizing U626F/R and Cas9F/R, positive seedling FANCM gene target sequences are amplified by PCR and are connected with T vectors to be sent to a biological engineering company for sequencing, sequencing results are compared, and meanwhile, an editing form is determined.
Wherein the BnaFANCM genes of the brassica napus comprise BnaFANCM-C05 and BnaFANCM-A05, the nucleotide sequence of the sgRNA is shown as SEQ.ID.NO.3, and the Target1 and the Target2 are common targets of the BnaFANCM-C05 and the BnaFANCM-A05 genes;
the nucleotide sequence of BnaFANCM-C05 is shown as SEQ.ID.NO.8, and the amino acid sequence is shown as SEQ.ID.NO. 10;
the nucleotide sequence of BnaFANCM-A05 is shown as SEQ ID.NO.9, and the amino acid sequence is shown as SEQ ID.NO. 11.
The primer sequences in step (1) are as follows:
DT 1 -BsF(SEQ.ID.NO.4):
ATATATGGTCTCGATTGAGTCCACACGAATTACTTAGTT
DT 2 -BsR(SEQ.ID.NO.5):
ATTATTGGTCTCGAAACGCTGAACTTTTTGCGACTGCAA
DT 1 -F0(SEQ.ID.NO.6):
TGAGTCCACACGAATTACTTAGTTTTAGAGCTAGAAATAGC
DT 2 -R0(SEQ.ID.NO.7):
AACGCTGAACTTTTTGCGACTGCAATCTCTTAGTCGACTCTAC
the agrobacterium in step (3) is agrobacterium GV3101, and the acceptor material is Y127.
The invention also provides application of the FANCM gene or the method in obtaining the male sterile mutant of the rape, and further, the application is to edit the FANCM gene by using a CRISPR/Cas9 system, so as to further obtain the male sterile mutant of the rape; further, the rape FANCM gene comprises BnaFANCM-C05 and BnaFANCM-A05.
The invention also provides a method for editing BnaFANCM through CRISPR/Cas9 to obtain BnaFANCM edited mutants fancm-1, fancm-2 and fancm-3, further observing the phenotype of the gene edited BnaFANCM mutant, and finding that the mutant shows a male sterile phenotype relative to a wild type; the method for obtaining a new male sterile plant by utilizing the CRISPR/Cas9 system directional mutation BnaFANCM provides a new germplasm resource for hybrid breeding of cabbage type rape and has wide application prospect in molecular design breeding of the rape.
In the invention, the BnaFANCM gene is edited, and the main editing type is that the insertion of T base causes the frame shift mutation of the gene.
The invention has the following advantages and beneficial effects:
at present, materials with natural mutation are screened and identified to obtain sterile lines, and physical ray mutagenesis or chemical mutagenesis is also manually carried out, and then the sterile lines are screened; the mutation rate of natural mutation and physicochemical mutation is low, a large amount of screening materials are needed, and manpower and material resources are greatly lost. Therefore, the invention focuses on the gene editing technology, and edits fertility genes to generate sterile line materials.
(1) In the invention, one of the limiting factors for limiting gene recombination or limiting the generation of new genotypes is relieved by editing the BnaFANCM gene, so that more genotypes are generated; the genotype determines the phenotype, so that a plurality of plants with different phenotypes can be finally generated, and the selection of favorable phenotypes for breeding is facilitated.
(2) The BnaFANCM gene is specifically knocked out in the cabbage type rape by adopting the method, so that single plants with different mutation types of BnaFANCM are obtained, and the fertility of the single plants is obviously reduced compared with that of a receptor material Y127;
(3) The method for obtaining a new sterile plant by utilizing CRISPR/Cas9 system directional mutation BnaFANCM provides a new germplasm resource for hybrid seed selection of brassica napus;
(4) The method provides an advantageous material for heterosis utilization in hybrid seed production, and has important theoretical and practical significance;
(5) The BnaFANCM mutant plant offspring can continuously generate new genotypes, and compared with natural mutation, the BnaFANCM mutant plant offspring accelerates the generation of new phenotypes;
(6) The gene editing vector pKSE401-BnaFANCM-CRISPR constructed by the invention converts rape to obtain a transformant, and provides experimental materials for researching the functions and action mechanisms of the gene BnaFANCM. The method of the invention can be applied to heterosis and three-line hybridization, and the obtained mutant plants are continuously mutated, namely the plants are sterile, but more genotypes are generated by increasing gene recombination when the plants are sterile and homozygous.
Drawings
FIG. 1 is a schematic representation of a pKSE401-BnafANCM-CRISPR vector; LB in the figure: a left boundary; RB: a right boundary; kan: kanamycin resistance gene; 35S: the CaMV35 promoter; u6-26p-Target1-gRNA: a group of gRNA expression elements comprising promoter U6-26p, target1 (Target 1) and a gRNA backbone structure; u6-26p-Target2-gRNA: a group of gRNA expression elements including promoter U6-26p, target2 (Target 2) and gRNA backbone structure; cas9: cas9 gene optimized according to codon.
FIG. 2 is a diagram of a PCR identification gel for extracting leaf genome from a positive plant obtained by transformation; in the figure, WT: wild type; fascm-1, fascm-2, fascm-3: a mutant transgenic plant; +: positive control, pKSE 401-bnafacm-CRISPR plasmid; -: negative control, ddH 2 O;Marker:Takara DL2000 DNA Marker。
FIG. 3 is a schematic diagram showing the analysis of the sequencing results of specific positions (a), bnaFANCM-C05 gene (b) and BnaFANCM-A05 gene (C) of the target point of BnaFANCM-C05 in the fancm mutant compared with the wild type.
FIG. 4 is a simplified schematic representation of frame shift mutations resulting from T insertion at the fancm mutant target 1; in the figure, (a) is an alteration of the BnaFANCM-C05 gene in the mutant compared to the wild type; (b) Is an alteration of the BnaFANCM-A05 gene in the mutant compared to the wild type.
FIG. 5 is a mutant material T 0 The phenotype observation of the self-copulation fruits of the partial strain of the generation and the phenotype observation of the back-and-forth copulation, wherein (a) is T 0 Observing the phenotype of the self-copulated fruits of the partial strain; (b) Is a positive and negative cross phenotype observation of the fascm mutant and the Wild Type (WT).
Detailed Description
In order to enable those skilled in the art to better understand the technical scheme of the present invention, the following detailed description of the preferred embodiments of the present invention is provided, but the following embodiments do not limit the scope of the present invention.
In the examples of the present invention, which are not described in detail, the processes involved in the examples are all performed by conventional experimental methods, and the materials or reagents not specifically described are all conventional commercially available materials, which are understood and easily implemented by those skilled in the art based on the product specification or the basic knowledge in the art, and thus will not be described in detail.
The culture medium and the formula thereof are as follows:
LB liquid medium: 10g of tryptone, 5g of yeast extract and 10g of sodium chloride are weighed and dissolved in 800mL of ddH 2 And (3) in O, the volume is fixed to 1L, then the mixture is split into 10 conical flasks and sealed by sealing films, the mixture is sterilized at the high temperature of 121 ℃ for 15min, cooled and then stored at the temperature of 4 ℃.
LB solid medium: weighing 10g of tryptone, 5g of yeast extract, 10g of sodium chloride and 15g of agar powder, dissolving in 800mL of ddH 2 And (3) in O, the volume is fixed to 1L, the mixture is split into 10 conical flasks and sealed by sealing films, the mixture is sterilized at the high temperature of 121 ℃ for 15min, cooled and then stored at the temperature of 4 ℃. When in use, the mixture is put into a microwave oven to be heated until the mixture is melted, the antibiotics are added when the liquid is cooled to about 50 ℃, and the mixture is immediately poured into a sterile plate after shaking, wherein each plate is about 10mL.
M0 Medium (1L): MS powder 4.4g, sucrose 30g,800ml ddH 2 Fully dissolving O, regulating the pH value to 5.84-5.88, fixing the volume to 1L, finally adding 10g of coagulant Agar, sterilizing, packaging into sterile plates, and placing into a refrigerator at 4 ℃ for standby.
DM medium (1L): MS powder 4.4g, sucrose 30g,800ml ddH 2 O is fully dissolved, the pH value is regulated to 5.84-5.88, the volume is fixed to 1L, the AS is added after the culture medium is cooled, 1mL AS (100 mu mol/mL of mother solution) is added into 1L, and the mixture is put into a refrigerator at 4 ℃ for standby.
M1 Medium (1L): MS powder 4.4g, sucrose 30g, mannitol 18g,2, 4-D1mg,KT 0.3mg,800ml ddH 2 O is fully dissolved, the pH value is regulated to 5.84-5.88, the volume is fixed to 1L, finally, 10g of coagulant agent and 10g of sterilization agent are added, AS is added after the culture medium is quickly cooled, 1mL of AS (mother liquor 100 mu mol/mL) is added into 1L, and then the mixture is packaged into a sterile plate and placed in a refrigerator at 4 ℃ for standby.
M2 medium (1L): MS powder 4.4g, sucrose 30g, mannitol 18g,2,4-D 1mg,KT 0.3mg,800ml ddH 2 o is fully dissolved, the pH value is regulated to 5.84-5.88, the volume is fixed to 1L, then 10g of coagulant agent, namely, agar is added, and after sterilization, the culture medium is quickly cooled and then added: temeitin 300mg, STS 150. Mu. Mol, kanamycin 25mg, and then split charged into sterile dishes and placed in a refrigerator at 4℃for use.
M3 Medium (1L): MS powder 4.4g, glucose 10g, xylose 0.25g,MES 0.6g,800ml ddH 2 O is fully dissolved, the pH value is regulated to 5.84-5.88, the volume is fixed to 1L, then 10g of coagulant agent, namely, agar is added, and after sterilization, the culture medium is quickly cooled and then added: ZT 2mg, IAA 0.1mg, timentin 300mg, agNO 3 150. Mu. Mol, 25mg kanamycin, and then split into sterile plates and placed in a refrigerator at 4℃for use.
M4 medium (1L): MS powder 4.4g, sucrose 10g,800ml ddH 2 O is fully dissolved, the pH value is regulated to 5.84-5.88, the volume is fixed to 1L, the coagulant agent is 10g, and after sterilization, the culture medium is added after quick cooling: 300mg of timentin is packaged and put in a refrigerator at 4 ℃ for standby.
STS:[Ag(SO 3 ) 2 ] 3- In the prior art, the mixture is prepared immediately, and precipitation exists for too long time; mother liquor: sodium thiosulfate, 0.1M (2.48 g in 100ml ddH) 2 O);AgNO 3 0.1M (1.7 g in 100ml ddH) 2 O)V Na2SO3 :V AgNO3 =4: 1, agNO3 was dissolved in sodium thiosulfate.
2,4-D (1 mg/ml): 1ml of 10mg/ml of mother liquor is taken in a 12ml sterile tube, 9ml of sterilized double distilled water is added, and the mixture is uniformly mixed and stored at the temperature of minus 20 ℃.
KT (1 mg/ml): 0.02g KT was first dissolved in 1M HCL, water was added to a volume of 20mL, and the mixture was stored at-20 ℃.
AS (100 umol/ml): 0.392g AS is firstly dissolved in a small amount of methanol, then dimethyl sulfoxide is added, the volume is fixed to 20m, suction filtration and split charging are carried out, and the mixture is stored at the temperature of minus 20 ℃.
ZT (2 mg/ml): 0.02. 0.02gZT powder is weighed and dissolved in a small amount of 75% alcohol, water is added to a constant volume to 10ml, and the mixture is filtered and split charging is carried out, and the mixture is stored at the temperature of minus 20 ℃.
IAA (1 mg/ml) 0.1g IAA was dissolved in a small amount of 1mol/LNaOH and ddH was added 2 O is fixed to 100ml, and the mixture is filtered and split charging is carried out, and the mixture is stored at the temperature of minus 20 ℃.
TMT (300 mg/ml) 3.2g of timentin powder was dissolved in 10.66ml of sterilized ddH 2 And (3) in the step O, shaking, mixing uniformly, carrying out suction filtration, split charging, and storing at the temperature of-20 ℃.
HYG (50 mg/ml): 1g of hygromycin B is dissolved in 20ml of sterilized ddH 2 And (3) in the step O, shaking, mixing uniformly, carrying out suction filtration, split charging, and storing at the temperature of-20 ℃.
Kana (100 mg/ml): 10g of kana powder is dissolved in 100ml of sterilized ddH2O, mixed evenly by shaking, filtered and split-packed and stored at-20 ℃.
Example 1: construction of CRISPR/Cas9 system-based directed mutation brassica napus BnaFANCM vector
According to sequence information of a reference genome ZS11 in a cabbage type rape reference genome website (http:// cbi.hzau.edu.cn/bnapus /), two FANCM homologous sequences, namely BnaFANCM-C05 and BnaFANCM-A05, are obtained, the nucleotide sequences of which are shown as SEQ ID NO.8 and SEQ ID NO.9, and the amino acid sequences of which are shown as SEQ ID NO.10 and SEQ ID NO. 11.
The specific sequence information of SEQ ID NO.8 and SEQ ID NO.9 is shown in the sequence list.
SEQ ID NO.10:
MGVDGVSYHRVSWGRYKDWAAVRDACKSNSSSSSTHTNDNGTKAKRSTDRDRSTDVVSDSCGTNDNTSVGDTAKTWYVNVRDYATKTASNTVATGGKTAAVVMYNYRWGKVAASRVMACHNVGWTDTGTCSKRASWKTKRVVTVKDSGTCVTNCVCVDAHRAGNYSYCVVVRMAVVRATATGSKTAGDNSTYRNSDHDVCYVHDRKVVGKDADVSKRDVRYAVRKNGVSRDYTSHMARDKRAVGHSHGDVSCAATYHRKSSHGRAYMKGARMSKNADRMTKMRSNGASKSKMVDHYKKDRTSRVSNRGSVRDMDASNGDVVKATGSSGKTKGSKVAVKRSGGNVVATSGGDMVDVCDANVSRMRMGRTGRKNNGRVACGSKNSYMRKKANGAKKHMRNGGMNSNHSRMHVYKVHVKSRGKKDAATAKKKTMDMAKYKNKWRVSAHTSKVHKVMHSRTSDAMHTTTSKSKYGAARDDAGRVGDDKDSDDDVNTSRKAKVVSTSTTTKASSTHCYNSCASVNTGKVVSSSNVGSDYVGRKSSNKSHDVVMDSSSKHRDSCKKGDCANTSSKWHSTDVGKGDNCSGMSSDDDCDSGSTSSRVAHSMTKHTKTKKTHRV
SEQ ID NO.11:
MGVDGDWAAVRDACKSNSSSSSTHTNGNGTKAKRSTDRARADHKYVVSDSCGTNDNTSVGDTAKTWYMNVRDYATKTASNTVATGGKTAAVVMYNYRWGKVAASRVMACHNVGWTDTGTCSKRASWKTKRVVTVKDSGTCVTNCVCVDAHRAGNYSYCVVVRMAVVRATATGSKTAGDNSTYRNSDHDVCYVHDRKVVGKDADVSKRDVRYAVRKNGVSRDYTSHMARDKRAVGHSHGDVSCAATYHRKSSHGRAYMKGARMSKNDRMTKMRSNGASKSKMVDHYKKDRTSRVSNRGSVRDMDASNDVVKATGSSGKTKGSKVAVKRSGGNVVATSGGDMVDVCDANVSRMRMGRTGRKNNGRVVVACGSKNSYMRKKANGAKKHMRNGGMNSNHSRMHVYKVHVKSRGKKDATTAKKKTMDMAKYKNKWRVSAHTSKVHKVMHSRTSDAMHTTTSKSKYGAARDDAGRVGDDKDSSDDDVNTSRKAKSTSTTTKDASSTHCYSSCASVDTGKVVVSSSNVGSDCVGRKSSNKSHTDVVDSSSKHRDNSCKKGDCANTSSKRHSTDVGKGDNCAGMSSDDDCDSRTNKSGVVDSVYDGVAYANRDDTSTNASTKKVHASTANRTKDANTSAVSMWRTANTNASSSASKDWRVSSGKSTRRKKRRRGDCSSAVKNNGAKTDHRSRSRSVKNRGKKKRADNNARAAVSSSMSVDNVDTSDSDSDDGTMTANTACAKVDMMAVYRRSSSARRDVAASSSYSSGKTNSRSDSDKSSSRTTTNNSNKDAVATGDVASTDSRKRKSCNSANVVNNKAHAATKSHGRSNAGASYKDDDDDAYATDDAMAHATSKRSTKTKDASVKHGNRNDGKDGSDGW
Submitting BnaFANCM-C05 gene sequence to CRISPR-P (http:// cbi. Hzau. Edu. Cn/cgi-bin/CRISPR) website, screening to determine that the off-Target rate is low and the Target sequence Target1 (the nucleotide sequence is shown as SEQ ID NO.1, TGG is a PAM sequence), target2 (the nucleotide sequence is shown as SEQ ID NO.2, AGG is a PAM sequence) and sgRNA (the nucleotide sequence is shown as SEQ ID NO.3, TGG is a PAM sequence) of the gene editing Target sequences of BnaFANCM-C05 and Bna FANCM-A05 can be edited simultaneously.
Target1 (nucleotide sequence shown as SEQ ID NO.1, TGG is PAM sequence):
GTTGCTTTACCAACAGGCCTTGG
target2 (nucleotide sequence shown as SEQ ID NO.2, AGG is PAM sequence):
GGTTTGCTTGGTGATCGACGAGG
sgRNA (nucleotide sequence shown as SEQ ID NO.3, TGG is PAM sequence):
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT
and designing CRISPR/Cas9 carrier target primers according to the screened targets, wherein the primer sequences are shown in table 1, and ensuring that 2 designed targets can be knocked out of BnaFANCM-C05 and BnaFANCM-A05 simultaneously.
TABLE 1 CRISPR/Cas9 vector target primers
Primer(s) | Sequence 5'-3' |
DT 1 -BsF(SEQ.ID.NO.4) | ATATATGGTCTCGATTGAGTCCACACGAATTACTTAGTT |
DT 2 -BsR(SEQ.ID.NO.5) | ATTATTGGTCTCGAAACGCTGAACTTTTTGCGACTGCAA |
DT 1 -F0(SEQ.ID.NO.6) | TGAGTCCACACGAATTACTTAGTTTTAGAGCTAGAAATAGC |
DT 2 -R0(SEQ.ID.NO.7) | AACGCTGAACTTTTTGCGACTGCAATCTCTTAGTCGACTCTAC |
Followed by entry vector pCBC-DT 1 T 2 As templates (from the university of agricultural chemical, china, programming, guo Liang) PCR amplification was performed with the pair of primers 2 shown in Table 1 under the action of high fidelity enzyme 2*Phanta Max Master Mix (available from Nanjinouzan Biotechnology Co., ltd.) and the PCR reaction system was as shown in Table 2.
TABLE 2 high fidelity enzyme PCR amplification reaction system
PCR component | Volume of |
2*Phanta Max Master Mix | 25μL |
DT 1 -BsF(10μM) | 1μL |
DT 2 -BsR(10μM) | 1μL |
DT 1 -F0(0.5μM) | 1μL |
DT 2 -R0(0.5μM) | 1μL |
pCBC-DT 1 T 2 (100-200ng) | 1μL |
ddH 2 O | 20μL |
The PCR reaction procedure was:
pre-denaturation at 95℃for 3min; denaturation at 95℃for 30s, annealing at 61℃for 30s, elongation at 72℃for 30s, and a total of 34 cycles; finally, the extension is carried out for 5min at 72 ℃.
After the completion of the PCR reaction, the PCR product was subjected to gel electrophoresis in a 1% agarose gel (mass volume fraction) at 120V 400mA for 27min, then photographed under an ultraviolet gel imager, and the result was recorded.
The results showed that there was a 626bp fragment, which was a fragment of the constructed vector target site and gRNA, cut into gel, and purified and recovered (purchased from Nanjinouzan Biotechnology Co., ltd.) using a FastPure Gel DNA Extraction Mini Kit kit. Then, an enzyme digestion connection system is established, and the specific connection system is shown in Table 3.
TABLE 3 cleavage-ligation System
After the reaction was completed, 5. Mu.L of ligation product was used to transform competent E.coli DH 5. Alpha. (purchased from Nanjinouzan Biotechnology Co., ltd.) and the transformed DH 5. Alpha. Was applied to a solid LB plate medium containing 50mg/mL Kan for screening, after overnight culture at 37℃positive clones were picked up in 400. Mu.L of liquid LB medium containing 50mg/mL Kan and shake-cultured in a shaker for 4-6 hours, and then 2. Mu.L of bacterial liquid was used as a template for PCR amplification for identification, the PCR amplification system was shown in Table 4, and the PCR reaction procedure was: pre-denaturation at 94℃for 3min; denaturation at 94℃for 30s, annealing at 57℃for 30s, elongation at 72℃for 40s, 28 cycles total; final extension at 72℃for 10min. The primers U626-IDF and U629R are universal primers, and the specific primer sequences are shown below
U626-IDF:TGTCCCAGGATTAGAATGATTAGGC(SEQ.ID.NO.12)
U629-IDR:AGCCCTCTTCTTTCGATCCATCAAC(SEQ.ID.NO.13);
TABLE 4 bacterial liquid PCR reaction system
Reaction components | Volume of |
Bacterial liquid | 2μL |
U626-IDF | 1μL |
U629R | 1μL |
rTaq enzyme | 10μL |
ddH 2 O | 6μL |
The PCR reaction procedure was: pre-denaturation at 94℃for 3min; denaturation at 94℃for 30s, annealing at 57℃for 30s, elongation at 72℃for 40s, 28 cycles total; final extension at 72℃for 10min.
The fragment size obtained after PCR gel running identification is 726bp, the sequence containing the target sequence and the sgRNA is connected to a final vector pKSE401 (from the professor Guo Liang of China agricultural university and available in the market), the fragment length is increased because of the fact that the sgRNA is also arranged on the final vector pKSE401, 150 mu L of positive clone bacterial liquid with correct fragment size is sucked and sent to a biological engineering (Shanghai) stock company for sequencing, and the sequence of the sequencing primers is U626-IDF and U629-IDF, wherein the sequence of the primers is as follows:
U626-IDF:TGTCCCAGGATTAGAATGATTAGGC(SEQ.ID.NO.12)
U629-IDF:TTAATCCAAACTACTGCAGCCTGAC(SEQ.ID.NO.14);
the correct clone was sequenced, the target was ligated to the sgRNA and present in the final vector, the plasmid was extracted, agrobacterium competent GV3101 (purchased from Shanghai Biotechnology Co., ltd.) was transformed, and a positive monoclonal was selected for Agrobacterium-mediated genetic transformation, and the vector pKSE401-BnafANCM-CRISPR schematic was shown in FIG. 1.
Example 2: transformation of pKSE401-BnaFANCM-CRISPR gene editing recombinant vector into cabbage type rape hypocotyl
(1) Seed disinfection and sowing
Selecting plump fast-growing rape Y127 (from university of agriculture Hong Dengfeng teacher in China) in a 12mL sterile tube, sterilizing with 75% alcohol in an ultra clean bench for 45s, and sterilizing with ddH 2 O washing seeds for 2-3 times, sterilizing with 15% Bleach solution (prepared as 8.115mL sterile water+1.875 mL sodium hypochlorite+10 μL triton) for 7min30s, and sterilizing with ddH 2 O cleaning the seeds until no obvious foam is present in the waterFinally, uniformly sowing the sterilized seeds to M 0 On the medium, dark culture was performed.
(2) Preparation of bacterial liquid
On day 7 after sowing, the GV301 Agrobacterium containing the pKSE401-BnafANCM-CRISPR recombinant vector obtained in example 1 was subjected to expansion culture: mu.L of recombinant bacteria solution was added with 5mL of resistant LB (50 mg/L Kan+50mg/L Gen+50mg/L Rif) and cultured at 28℃for about 14-16h in a shaker at 220 rpm.
(3) Infection and co-cultivation
And (3) measuring the OD value of the bacteria in the resistant LB medium in the step (2) by using a spectrophotometer, wherein the bacterial liquid is better when the OD value is about 0.4, and the bacteria are generally shaken for 14-16 hours. Sucking 2mL of the cultured bacterial liquid into a 2mL sterile centrifuge tube, centrifuging at 5000rpm for 10min, and discarding the supernatant; then 2mL of DM (AS+) solution was added to suspend, centrifuged at 5000rpm for 10min, and the supernatant was discarded; then, 2mL of DM (AS+) was added to the suspension, and the suspension was kept in a refrigerator at 4℃for further use.
Taking out seedlings which are dark-cultured for 7 days, cutting hypocotyls by using forceps and scissors which are sterilized at high temperature, placing the hypocotyls in a disposable plate with 18ml DM (AS+) and cutting the hypocotyls downwards AS quickly AS possible, and ensuring that the incision is flat and the length is 0.8-1 cm. After cutting, adding a prepared bacterial liquid, dip-dyeing for 12min30 s, and shaking for 1 time and 4-5 times at intervals; the DM (AS+) and bacterial liquid are sucked by a gun head, the hypocotyl explant is paved on filter paper sterilized in advance, and the bacterial liquid with excessive surface is sucked. The explants were uniformly swung to M with forceps 1 On the culture medium, the two ends of the explant are fully contacted with the culture medium when the explant is placed, and the explant is subjected to dark culture at 24 ℃ for 36-48h.
(4) Selective culture and callus induction
M after co-cultivation (co-cultivation of transformed recombinant Agrobacterium with hypocotyl) 1 Transfer of the intermediate explant to M for selection and callus induction 2 M on the culture medium 2 The explants in the culture medium are cultured normally under inverted light, the culture conditions are that the culture is carried out alternately in a mode of 16 hours in the daytime and 8 hours in the evening at 24 ℃, and the callus is induced for 2-3 weeks.
(5) Redifferentiation
Transfer of selected explants to differentiation M 3 Every 2 to 3 on the culture mediumZhou Jidai dead brown explants are eliminated during this period, preferably those with two enlarged ends and green spots until green buds appear.
(6) Rooting culture
Cutting part of wound on the bud seedling base with high temperature sterilized surgical knife, and transferring into M 4 Rooting culture is carried out in a culture medium. After rooting, the seedlings can be placed in a culture room for hardening, after the seedling state is stable, the seedlings are taken out from a culture medium, the root systems of the plants are not damaged as much as possible in the seedling taking process, then the root systems are soaked with 1% carbendazim for one time, finally the seedlings are moved into soil for culture, and the transgenic rape waiting for identification can be obtained by using a preservative film to preserve moisture for about 1 week during the culture.
Example 3: transgenic plant editing situation detection
(1) Extraction of transgenic plant DNA
The DNA in the transgenic rape leaves is extracted by adopting a CTAB method, and the specific steps are as follows:
taking thumb cover big and small blades, putting the thumb cover big and small blades into a 1.5mL centrifuge tube, refrigerating in liquid nitrogen, grinding by a grinding gun, adding 600 mu L of CTAB after grinding into dry powder, fully shaking, and then putting a sample into a 65 ℃ water bath for incubation for 60min; after the incubation was completed, 600. Mu.L of chloroform/isoamyl alcohol (24:1 by volume) solution was added to the tube, vigorously shaken, and the protein was removed thoroughly, and then placed in a centrifuge for centrifugation at 12000g for 10min; sequentially placing the centrifuged centrifugal tubes on an operation board, and sucking 400 mu L of supernatant into a new 1.5mL centrifugal tube, wherein the residual tissues below the supernatant are not required to be sucked into the new centrifugal tube; then 400 mu L of isopropanol is added into the supernatant, the mixture is gently inverted and uniformly mixed, and then the sample is placed into a refrigerator with the temperature of minus 20 ℃ to be cooled for at least 10min so as to lead the DNA to be completely precipitated; putting the centrifuge tube into a centrifuge, and centrifuging 12000g for 10min at room temperature; the supernatant was discarded, and the precipitate (pop-up bottom precipitate) was washed with 700. Mu.L of 70% ice-ethanol, 12000g of the solution was spun; discarding the supernatant, sucking the residual liquid by a pipetting gun, and drying and precipitating in an ultra-clean bench for 10min; add 50. Mu.L ddH to centrifuge tube 2 O is dissolved and precipitated, and the obtained product is put into a water bath kettle at 37 ℃ for 60min to obtain a genome DNA sample; finally 1 mu L of base is takenThe concentration of the group sample was measured, and after the detection was passed (OD 260 /OD 280 Between 1.6 and 1.8), and placing the genome sample in a refrigerator at-20 ℃ for standby.
(2) Identification of positive seedlings
Using the DNA extracted in the step (1) as a template, and using primers U626-IDF, U626-IDR and Cas9-F, cas-R to perform PCR amplification respectively, wherein the DNA of water and wild type Y127 is used as a negative control, the plasmid pKSE401-BnaFANCM-CRISPR is used as a positive control, the annealing temperature is 57 ℃ and 62 ℃, other PCR amplification reaction procedures and conditions are the same as those of the bacterial liquid PCR reaction of the table 4, and the primer sequences are as follows:
U626-IDF:TGTCCCAGGATTAGAATGATTAGGC(SEQ.ID.NO.12)
U629-IDR:AGCCCTCTTCTTTCGATCCATCAAC(SEQ.ID.NO.13);
Cas9-F:TGCAGGAGATTTTCTCCAACGA(SEQ.ID.NO.15)
Cas9-R:AGCCTTCGTAATCTCGGTGTTCA(SEQ.ID.NO.16)
after the PCR was completed, the amplified product was electrophoresed in 1% agarose gel, photographed using an ultraviolet gel imager, and the result was recorded. FIG. 2 is a diagram of a PCR identification gel for extracting leaf genome from 3 positive strains obtained from 14 strains through transformation screening; in the figure, WT: wild type; fascm-1, fascm-2, fascm-3: a mutant transgenic plant; +: positive control, pKSE 401-bnafacm-CRISPR plasmid; -: negative control, ddH 2 O; marker: takara DL2000 DNA Marker; as can be seen from the figures, fancm-1, fancm-2 and fancm-3 are transgenic positive plants.
(3) TA cloning detection positive seedling editing site
The genome of the positive strain successfully identified is subjected to PCR amplification, gel running, gel recovery and pMD19-T vector connection by using high-fidelity enzyme under the action of a primer C05OEF/C4C5R, escherichia coli is transformed, bacterial selection identification is carried out, and monoclonal bacterial liquid is sent to a biological engineering (Shanghai) stock company for sequencing, and specific experimental operation and method are as follows:
the 1000bp fragments near Target1 and Target2 of the BnaFANCM genome were amplified using high fidelity enzyme 2*Phanta Max Master Mix (available from Nanjinouzan Biotechnology Co., ltd.) using leaf DNAs of rape variety Y127 (from Huazhong university of agriculture), fancm-1, fancm-2, fancm-3 as templates, respectively, and PCR reactions were as shown in Table 5.
TABLE 5 high fidelity enzyme amplification BnaFANCM genome reaction System
PCR component | Volume of |
2*Phanta Max Master Mix | 25μL |
C05OEF(10μM) | 2μL |
C4C5R(10μM) | 2μL |
DNA(100-200ng) | 1μL |
ddH 2 O | 20μL |
The PCR reaction procedure was: pre-denaturation at 95℃for 3min; denaturation at 95℃for 30s, annealing at 57℃for 30s, elongation at 72℃for 1min for 30s, 34 cycles in total; finally, the extension is carried out for 5min at 72 ℃.
After the completion of the PCR reaction, the PCR product was subjected to gel electrophoresis in a 1% agarose gel (mass volume fraction) at 120V 400mA for 27min, then photographed under an ultraviolet gel imager, and the result was recorded. The result shows that the 1322bp fragment is available, the gel is cut, and FastPure Gel DNA Extraction Mini Kit reagent is utilizedThe PCR product was recovered by cassette purification (purchased from Nanjinozan Biotechnology Co., ltd.). Then, the recovered PCR amplified product is subjected to end addition A, and an A adding system is as follows: recovery of the product 7.5. Mu. L, dNTPs 1. Mu.L, PCR Buffer (Mg + free) 1. Mu. L, rTaq 0.5.5. Mu.L, reaction conditions 72℃for 30min. The addition A product was then ligated to the pMD19-T vector in the following manner: the ligation product (TA cloning reagents were obtained from Takara Bio Inc. were used) was obtained by ligation overnight at 16℃with 4.5. Mu. L, pMD-19T vector 0.5. Mu. L, solution I5. Mu.L.
mu.L of ligation product was added to 30. Mu.L of competent cells of E.coli (purchased from Nanjinouzan Biotechnology Co., ltd.) and transferred into E.coli by heat shock method, positive colonies were screened using LB medium containing Amp at a final concentration of 30mg/mL, 12 single colonies were picked up and shake-cultured for 12-16 hours, 2. Mu.L of bacterial liquid was taken as template for PCR amplification for identification, and the primers were C05OEF/C4C5R, and other PCR reaction conditions and procedures were as follows with reference to Table 4:
C05OEF:GGTACCATGGGACCCGAGTTTCCGAT(SEQ.ID.NO.17)
C4C5R:CTGAAAAATGGCATCCAACAAG(SEQ.ID.NO.18)
the positive monoclonal bacterial liquid is sent to a biological engineering (Shanghai) stock company for sequencing, the obtained sequencing result is analyzed, the sequencing result is summarized as shown in figure 3, more monoclonal bacteria can be found to show T base insertion at a target point 1, so that the further analysis is carried out, and the analysis result is shown in figure 4.
FIG. 4 is a simplified schematic diagram of a frame shift mutation resulting from the insertion of T at the fancm mutant target 1; in the figure, (a) is an alteration of the BanFANCM-C05 gene in the mutant compared to the wild type; (b) Is an alteration of the BanFANCM-A05 gene in the mutant compared to the wild type. As can be seen from the graphs (a) and (b), the frame shift mutation occurs in both the BanFANCM-C05 and BanFANCM-A05 genes of the fascm mutant, so that the translation process of the FANCM gene is terminated in advance, and the FANCM protein cannot be synthesized normally, which proves that the gene editing vector successfully functions at a target point, and the BanFANCM-C05 and BanFANCM-A05 genes are successfully knocked out in brassica napus.
Example 4: phenotype observation of Gene editing plants
The 3-strain gene-edited oilseed rape obtained in example 3 was subjected to self-pollination every day, and after one week, the fancm mutant was found to exhibit a sterile phenotype, as shown in FIG. 5 (a), and to further determine whether the fancm mutant was male sterile or female sterile, a positive and negative crossing experiment was performed on the mutant material. As shown in FIG. 5 (b), the delivery of the mutant material pollen to the Y127 column head of the recipient material was non-horn yielding, and the delivery of Y127 pollen to the mutant was horn yielding, demonstrating that the Bnafacm mutant was male sterile. The number of the positive and negative fruits is shown in Table 6.
TABLE 6 statistics of the number of orthogonal results of fascm mutants and Wild Type (WT)
Seed WT (fruit number of fruit/emasculation number) | Male WT (fruit number/emasculation number) | |
fancm-1 | 0/5 | 4/6 |
fancm-2 | 0/5 | 4/5 |
fancm-3 | 0/5 | 4/5 |
It should be understood that the above-described embodiments are merely illustrative of or explanatory of the general principles of the invention, and the invention is not limited to the above-described embodiments, but may be variously changed and modified without departing from the spirit and scope of the invention, which is defined by the appended claims and their equivalents.
Sequence listing
<110> university of Jiangsu
<120> BnaFANCM gene, application and method for obtaining male sterile mutant of rape
<160> 18
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
gttgctttac caacaggcct tgg 23
<210> 2
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
ggtttgcttg gtgatcgacg agg 23
<210> 3
<211> 83
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
gttttagagc tagaaatagc aagttaaaat aaggctagtc cgttatcaac ttgaaaaagt 60
ggcaccgagt cggtgctttt ttt 83
<210> 4
<211> 39
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
atatatggtc tcgattgagt ccacacgaat tacttagtt 39
<210> 5
<211> 39
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
attattggtc tcgaaacgct gaactttttg cgactgcaa 39
<210> 6
<211> 41
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
tgagtccaca cgaattactt agttttagag ctagaaatag c 41
<210> 7
<211> 43
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
aacgctgaac tttttgcgac tgcaatctct tagtcgactc tac 43
<210> 8
<211> 2922
<212> DNA
<213> cabbage type rape (Brassica napus)
<400> 8
atgggacccg agtttccgat cgaactcgtt gaagaagaag atggagtgag ttaccaccga 60
gtctctttct ggctgggtca attcagattt ccttatttaa aattattttt gtttttgcag 120
ttcgattggg aagcagcagt cagagaaatc gacttggctt gcctcaaatc cttaaaccct 180
tcttcttctt cttcgaccca tttcaccaac gacaatggca ctaaacctgc taaaagacaa 240
tctactctcg atcgattcat cgatcgatct actccggatc ctcctgttgt ttccgacccg 300
agtttcgagt gtggtactaa cgacaacact cccagcgtcg ggattgatcc tgagacagct 360
aaaacttgga tttatccagt aaacgttcct ctaagagatt atcagtttgc tataaccaag 420
actgctttgt tttcaaacac attagttgct ttaccaacag gccttggtaa aacgctcata 480
gctgcagttg taatgtataa ttacttcaga tggtttccac aaggtaaaat tgtctttgcc 540
gcaccttcta ggcctcttgt gatgcagcag attgaggcct gccataatat cgtggggata 600
ccacaagaat ggacgattga cttgacgggt cagacttgcc cttccaaaag agcttccttg 660
tggaaaacca aaagggtttt cttcgtcact ccacaagttc ttgagaagga tatacagtca 720
ggaacgtgtg ttaccaactg cttggtttgc ttggtgatcg acgaggcaca tcgagcttta 780
gggaattatt cttattgtgt tgtagttcgt gagttgatgg cagtaccagt gcagttgaga 840
atattggctc ttactgcaac tcctggatca aagacacagg ccatacaggg tatccttgat 900
aatttgcaga tatcaacact tgaatatcga aacgagagtg accatgatgt ctgcccttat 960
gtccacgaca gaaaagtaga actaatcgag gttcccttgg gtaaagatgc agatgaggta 1020
tctaaacgcc tattagatgt tatacgtcca tatgcagtca ggcttaaaaa tttcggggtc 1080
attctaagca gggattatca aactttgagt ccacacgaat tacttatggc aagggataag 1140
tttcgtgaag cacctgtacc aggcattccc catataagtc acggagatgt agaatcttgc 1200
tttgcagctc ttatcacgct ttatcacatt cgcaagcttc tttctagtca tggaataagg 1260
ccagcgtatg agatgcttga agaaaaactc caggaagggc catttgctag gttgatgagt 1320
aagaatgcag atattaggat gacgaagctt ttgatgcagc aaaggttgtc gaacggagca 1380
ccaagcccga aattgtccaa gatgttggag attctagttg atcactacaa aataaaagat 1440
ccgaggacat cacgggtcat tattttctcg aatttcagag gaagcgtaag agacataatg 1500
gacgcattaa gtaatattgg agatgttgtc aaagcaactg agtttattgg tcaaagttca 1560
ggtaagacac tgaagggaca gtcgcaaaaa gttcagcagg ctgttctgga gaaatttaga 1620
tctggtgggt ttaatgttat tgttgcaaca tctatcggcg aagaaggctt ggatatcatg 1680
gaagtcgact tagttatatg ttttgatgct aatgtatccc ctctgaggat gatccaacgc 1740
atgggaagaa ctggaaggaa aaataatggc cgacctttac tagttcttgc ttgtgaagga 1800
tctgaaaaga atagctatat gcgaaagaaa gcaaatggcc aagccattaa aaaacacatg 1860
cggaatggag gaatgaatag ttttaatttt catcctagtc caaggatgat tccccatgtt 1920
tataagccag aagttcagca tgttaagttt tcgatcgagc aattcattcc acgtggaaag 1980
aagctacaag atgagcctgc cgctgagact ccagctttca agaaaaagct tacaccggaa 2040
gagatggata tgctcgccaa gtatttcaaa cccaacgagg aaaagtggag agtttccttg 2100
attgctttcc ctcacttcca aacattgcca tccaaagtgc acaaagtaat gcattcacgc 2160
caaacaagca tattaattga tgctatgcag catctgcaag agacaacttt gacagagcaa 2220
agtaaaagct tcttcattaa gtatggagct cctttggctg aaagagatga gcttgacgca 2280
ggtctgaggg ttggtgatga tccgaaagat ttaccctctt tcgatgattt ggatgtcaac 2340
acatcacaga gaaaggcaaa acaagttgta gaatctccca caagcacatt agagactaca 2400
gagaaggaat tcgaagcatc ttcaccaaca cactgttatc ttttcaattc ggaatgtgcg 2460
tccgttaata ctctggggaa ggtctttata ttgccggttc ctctttcatt atcttctaat 2520
gtaccagggt cagactatgt gggaagagaa aaagaacttt cttccccgaa taaatcccac 2580
attgacgttg ttccgatgga tagttcctca aaacatcggc aagatagtat tccatgcaag 2640
ttaaagcaag gattcttgcc agattgtgcc aacgagactt tggagtccca aagccttttg 2700
aaatggcact ccaccgatgt aggtaaagga gatatagaga attgttctgg agaaattatg 2760
atatcatcgg atgaagaaga cgactgtgag gatttggagc ttagtcaagg ctcactaact 2820
tcatcaagag tggcgttgtt ccagattcac ctgtctatga ccaaggagtt gcatacgaag 2880
caaacagaga agaagacctt gatcttccac ccacgagttt aa 2922
<210> 9
<211> 3993
<212> DNA
<213> cabbage type rape (Brassica napus)
<400> 9
atgggacccg agtttccgat cgaactcgtt gaagaagaag atggattcga ttgggaagca 60
gcagtcagag aaatcgactt ggcttgcctc aaatccttaa acccttcttc ttcttcttcg 120
acccatttca ccaacggcaa tggcactaaa cctgctaaaa gacaatctac tcttgatcga 180
ttcatcgcaa gagccgacca caagcctcct cctccgtatc ctcctgttgt ttccgacccg 240
agtttcgagt gtggtactaa cgacaacact cccagcgtcg ggattgatcc tgagacagct 300
aaaacttgga tttatccaat gaacgttcct ctaagagatt atcagtttgc tataacgaag 360
actgctttgt tttcaaacac attagttgct ttaccaacag gccttggtaa aacgctcata 420
gctgcagttg taatgtataa ttacttcaga tggtttccac aaggtaaaat tgtctttgcc 480
gcaccttcta ggcctcttgt gatgcagcag attgaggcct gccataatat cgtggggata 540
ccacaagaat ggacgattga cttgacgggt cagacttgcc cttccaaaag agcttccttg 600
tggaaaacca aaagggtttt cttcgtcact ccacaagttc ttgagaagga tatacagtca 660
ggaacgtgtg ttaccaactg cttggtttgc ttggtgatcg acgaggcaca tcgagcttta 720
gggaattatt cttattgtgt tgtagttcgt gagttgatgg cagtaccagt gcagttgaga 780
atattggctc ttactgcaac tcctggatca aagacacagg ccatacaggg tatccttgat 840
aatttgcaga tatcaacact tgaatatcga aacgagagtg accatgatgt ctgcccttat 900
gtccacgaca gaaaagtaga actaatcgag gttcccttgg gtaaagatgc agatgaggta 960
tctaaacgcc tattagatgt tatacgtcca tatgctgtca ggcttaaaaa tttcggggtc 1020
attctaagca gggattatca aactttgagt ccacacgaat tacttatggc aagggataag 1080
tttcgtgaag cacctgtacc aggcattccc catataagtc acggagatgt agaatcttgc 1140
tttgcagctc ttatcacgct ttatcacatt cgcaagcttc tttctagtca tggaataagg 1200
ccagcgtatg agatgcttga agaaaaactt caggaagggc catttgctag gttgatgagt 1260
aagaatgaag atattaggat gacgaagctt ttgatgcagc aaaggttgtc gaacggagca 1320
ccaagcccga aattgtccaa gatgttggag attctagttg atcactacaa aataaaagat 1380
ccgaggacat cacgggtcat tattttctcg aatttcagag gaagcgtaag agacataatg 1440
gacgcattaa gtaatattga agatgttgtc aaagcaactg agtttattgg tcaaagttca 1500
ggtaagacac tgaagggaca gtcgcaaaaa gttcagcagg ctgttctgga gaaatttaga 1560
tctggtgggt ttaatgttat tgttgcaaca tctatcggcg aagaaggctt ggatatcatg 1620
gaagtcgact tagttatatg ttttgatgct aatgtatccc ctctgaggat gatccaacgc 1680
atgggaagaa ctggaaggaa aaataatggc cgagttgtag ttcttgcttg tgaaggatct 1740
gaaaagaata gctatatgcg aaagaaagca aatggccaag ccattaaaaa acacatgcgg 1800
aatggaggaa tgaatagttt taattttcat cctagtccaa ggatgattcc ccatgtttat 1860
aagccagaag ttcagcatgt taagttttcg atcgagcaat tcattccacg tggaaagaag 1920
ctacaagatg agcctgccac tgagactcca gctttcaaga aaaagcttac accggaagag 1980
atggatatgc tcgccaagta tttcaaaccc aacgaggaaa agtggagagt ttccttgatt 2040
gctttccctc acttccaaac attgccatcc aaagtgcaca aagtaatgca ttcacgccaa 2100
acaagcatat taattgatgc tatgcagcat ctgcaagaga caactttgac agagcaaagt 2160
aaaagtttct tcattaagta tggagctcct ttggctgaaa gagatgagct tgacgcaggt 2220
ctgagggttg gtgatgatcc gaaagattta ccctcttccg atgatttgga tgtcaacaca 2280
tcacagagaa aggcaaaaca aattttagaa tctcccacaa gcacattaga gactacagag 2340
aaggatttcg aagcatcttc acccacacac tgttatcttt tcagttcaga atgtgcgtcc 2400
gttgatactc tggggaaggt ctttgtattg ccggttcctc tctcattctc ttctaatgta 2460
ccagggtcag actgcgtggg aagagaaaaa gaactttctt ccccgaataa gtcccacact 2520
gacgttgttc cgatagatag ttcctcaaaa catcggcaag ataatatttc atgcaagtta 2580
aagcaaggat tcttgccaga ttgtgccaac gagactttgg agtcccaaag ccttttgaaa 2640
aggcactcca ccgatgtagg taaaggagat atagagaatt gtgctggaga aattatgata 2700
tcatcggatg aagaagacga ctgtgaggat ttggagctta gtccaaggct cactaacttc 2760
atcaagagtg gcgttgttcc agattcacct gtctatgacc aaggagttgc atacgaagca 2820
aacagagaag aagaccttga tcttccaccc acgagtttaa ctaatgaatt ggcagaagag 2880
ccatcgacac ctgagaaaaa ggttcacatt gcttctacgg ccaatgaatt cagaactcct 2940
cagaaggaag aagatttagc caacgaaaca gaaagcttcg ctgtttctcc aatgcctgag 3000
gagtggagaa ctcccttggc gaatatcacc aacgcaagca gcagcgctag caaagattgg 3060
cgcgtgagtt cgggagaaaa gtcagaaact cttcgacagc ctcgcaagtt gaagagactt 3120
cgtagacttg gagattgctc gagtgctgtg aaggagaata atcctggtat tgcaaagaca 3180
gaccatatca gatctcgttc tcgcagtgta aagaacataa gaggcaagaa gaagatacgc 3240
gcggataata atgctagaat cttcattgaa gcggaagctg aggtgtcttc ggaatcagaa 3300
atgtcggttg atgagaacgt agatttgacc agcgattcat ttgaagatag cttcatagat 3360
gacggtacaa tgcctacagc aaatactcaa gccgagtgtg ctaaagttga catgatggcc 3420
gtttacagac gttctctact cagccaatca ccattaccgg caagatttcg tgatgtagct 3480
gcatcaagtc cgagtcctta ttcttctggt ctcttgaaga caataaatga gagcagaagc 3540
gactcagata aatcattgtc ttctcttaga accccacaaa caacgaacaa cgagtcaaac 3600
aaggatgcag tggccacagg agactttttg gtagcacaaa tctcaacaga cagccggaaa 3660
aggaaattca gcttatgcaa ctcagcgaat gtcccagtga ttaacttgga aaacaagttt 3720
gaagctcatg cacaagccac ggagaaggaa agccatgaag gtccgagaag caatgcaggt 3780
gcatcacagt acaaggatga ggatgaagat gatgatgcat tctacgcgac actggacttt 3840
gatgccatgg aagcgcatgc gacattgcta ttgtcgaaac aaaggtcaga aacgaaaaca 3900
aaagaagatg catcggtgaa acctcatttg ggcaatcaga ggaatgatgg tttgccgaag 3960
gatgggccat cttttgatct tggtttgtgg tga 3993
<210> 10
<211> 615
<212> PRT
<213> cabbage type rape (Brassica napus)
<400> 10
Met Gly Val Asp Gly Val Ser Tyr His Arg Val Ser Trp Gly Arg Tyr
1 5 10 15
Lys Asp Trp Ala Ala Val Arg Asp Ala Cys Lys Ser Asn Ser Ser Ser
20 25 30
Ser Ser Thr His Thr Asn Asp Asn Gly Thr Lys Ala Lys Arg Ser Thr
35 40 45
Asp Arg Asp Arg Ser Thr Asp Val Val Ser Asp Ser Cys Gly Thr Asn
50 55 60
Asp Asn Thr Ser Val Gly Asp Thr Ala Lys Thr Trp Tyr Val Asn Val
65 70 75 80
Arg Asp Tyr Ala Thr Lys Thr Ala Ser Asn Thr Val Ala Thr Gly Gly
85 90 95
Lys Thr Ala Ala Val Val Met Tyr Asn Tyr Arg Trp Gly Lys Val Ala
100 105 110
Ala Ser Arg Val Met Ala Cys His Asn Val Gly Trp Thr Asp Thr Gly
115 120 125
Thr Cys Ser Lys Arg Ala Ser Trp Lys Thr Lys Arg Val Val Thr Val
130 135 140
Lys Asp Ser Gly Thr Cys Val Thr Asn Cys Val Cys Val Asp Ala His
145 150 155 160
Arg Ala Gly Asn Tyr Ser Tyr Cys Val Val Val Arg Met Ala Val Val
165 170 175
Arg Ala Thr Ala Thr Gly Ser Lys Thr Ala Gly Asp Asn Ser Thr Tyr
180 185 190
Arg Asn Ser Asp His Asp Val Cys Tyr Val His Asp Arg Lys Val Val
195 200 205
Gly Lys Asp Ala Asp Val Ser Lys Arg Asp Val Arg Tyr Ala Val Arg
210 215 220
Lys Asn Gly Val Ser Arg Asp Tyr Thr Ser His Met Ala Arg Asp Lys
225 230 235 240
Arg Ala Val Gly His Ser His Gly Asp Val Ser Cys Ala Ala Thr Tyr
245 250 255
His Arg Lys Ser Ser His Gly Arg Ala Tyr Met Lys Gly Ala Arg Met
260 265 270
Ser Lys Asn Ala Asp Arg Met Thr Lys Met Arg Ser Asn Gly Ala Ser
275 280 285
Lys Ser Lys Met Val Asp His Tyr Lys Lys Asp Arg Thr Ser Arg Val
290 295 300
Ser Asn Arg Gly Ser Val Arg Asp Met Asp Ala Ser Asn Gly Asp Val
305 310 315 320
Val Lys Ala Thr Gly Ser Ser Gly Lys Thr Lys Gly Ser Lys Val Ala
325 330 335
Val Lys Arg Ser Gly Gly Asn Val Val Ala Thr Ser Gly Gly Asp Met
340 345 350
Val Asp Val Cys Asp Ala Asn Val Ser Arg Met Arg Met Gly Arg Thr
355 360 365
Gly Arg Lys Asn Asn Gly Arg Val Ala Cys Gly Ser Lys Asn Ser Tyr
370 375 380
Met Arg Lys Lys Ala Asn Gly Ala Lys Lys His Met Arg Asn Gly Gly
385 390 395 400
Met Asn Ser Asn His Ser Arg Met His Val Tyr Lys Val His Val Lys
405 410 415
Ser Arg Gly Lys Lys Asp Ala Ala Thr Ala Lys Lys Lys Thr Met Asp
420 425 430
Met Ala Lys Tyr Lys Asn Lys Trp Arg Val Ser Ala His Thr Ser Lys
435 440 445
Val His Lys Val Met His Ser Arg Thr Ser Asp Ala Met His Thr Thr
450 455 460
Thr Ser Lys Ser Lys Tyr Gly Ala Ala Arg Asp Asp Ala Gly Arg Val
465 470 475 480
Gly Asp Asp Lys Asp Ser Asp Asp Asp Val Asn Thr Ser Arg Lys Ala
485 490 495
Lys Val Val Ser Thr Ser Thr Thr Thr Lys Ala Ser Ser Thr His Cys
500 505 510
Tyr Asn Ser Cys Ala Ser Val Asn Thr Gly Lys Val Val Ser Ser Ser
515 520 525
Asn Val Gly Ser Asp Tyr Val Gly Arg Lys Ser Ser Asn Lys Ser His
530 535 540
Asp Val Val Met Asp Ser Ser Ser Lys His Arg Asp Ser Cys Lys Lys
545 550 555 560
Gly Asp Cys Ala Asn Thr Ser Ser Lys Trp His Ser Thr Asp Val Gly
565 570 575
Lys Gly Asp Asn Cys Ser Gly Met Ser Ser Asp Asp Asp Cys Asp Ser
580 585 590
Gly Ser Thr Ser Ser Arg Val Ala His Ser Met Thr Lys His Thr Lys
595 600 605
Thr Lys Lys Thr His Arg Val
610 615
<210> 11
<211> 872
<212> PRT
<213> cabbage type rape (Brassica napus)
<400> 11
Met Gly Val Asp Gly Asp Trp Ala Ala Val Arg Asp Ala Cys Lys Ser
1 5 10 15
Asn Ser Ser Ser Ser Ser Thr His Thr Asn Gly Asn Gly Thr Lys Ala
20 25 30
Lys Arg Ser Thr Asp Arg Ala Arg Ala Asp His Lys Tyr Val Val Ser
35 40 45
Asp Ser Cys Gly Thr Asn Asp Asn Thr Ser Val Gly Asp Thr Ala Lys
50 55 60
Thr Trp Tyr Met Asn Val Arg Asp Tyr Ala Thr Lys Thr Ala Ser Asn
65 70 75 80
Thr Val Ala Thr Gly Gly Lys Thr Ala Ala Val Val Met Tyr Asn Tyr
85 90 95
Arg Trp Gly Lys Val Ala Ala Ser Arg Val Met Ala Cys His Asn Val
100 105 110
Gly Trp Thr Asp Thr Gly Thr Cys Ser Lys Arg Ala Ser Trp Lys Thr
115 120 125
Lys Arg Val Val Thr Val Lys Asp Ser Gly Thr Cys Val Thr Asn Cys
130 135 140
Val Cys Val Asp Ala His Arg Ala Gly Asn Tyr Ser Tyr Cys Val Val
145 150 155 160
Val Arg Met Ala Val Val Arg Ala Thr Ala Thr Gly Ser Lys Thr Ala
165 170 175
Gly Asp Asn Ser Thr Tyr Arg Asn Ser Asp His Asp Val Cys Tyr Val
180 185 190
His Asp Arg Lys Val Val Gly Lys Asp Ala Asp Val Ser Lys Arg Asp
195 200 205
Val Arg Tyr Ala Val Arg Lys Asn Gly Val Ser Arg Asp Tyr Thr Ser
210 215 220
His Met Ala Arg Asp Lys Arg Ala Val Gly His Ser His Gly Asp Val
225 230 235 240
Ser Cys Ala Ala Thr Tyr His Arg Lys Ser Ser His Gly Arg Ala Tyr
245 250 255
Met Lys Gly Ala Arg Met Ser Lys Asn Asp Arg Met Thr Lys Met Arg
260 265 270
Ser Asn Gly Ala Ser Lys Ser Lys Met Val Asp His Tyr Lys Lys Asp
275 280 285
Arg Thr Ser Arg Val Ser Asn Arg Gly Ser Val Arg Asp Met Asp Ala
290 295 300
Ser Asn Asp Val Val Lys Ala Thr Gly Ser Ser Gly Lys Thr Lys Gly
305 310 315 320
Ser Lys Val Ala Val Lys Arg Ser Gly Gly Asn Val Val Ala Thr Ser
325 330 335
Gly Gly Asp Met Val Asp Val Cys Asp Ala Asn Val Ser Arg Met Arg
340 345 350
Met Gly Arg Thr Gly Arg Lys Asn Asn Gly Arg Val Val Val Ala Cys
355 360 365
Gly Ser Lys Asn Ser Tyr Met Arg Lys Lys Ala Asn Gly Ala Lys Lys
370 375 380
His Met Arg Asn Gly Gly Met Asn Ser Asn His Ser Arg Met His Val
385 390 395 400
Tyr Lys Val His Val Lys Ser Arg Gly Lys Lys Asp Ala Thr Thr Ala
405 410 415
Lys Lys Lys Thr Met Asp Met Ala Lys Tyr Lys Asn Lys Trp Arg Val
420 425 430
Ser Ala His Thr Ser Lys Val His Lys Val Met His Ser Arg Thr Ser
435 440 445
Asp Ala Met His Thr Thr Thr Ser Lys Ser Lys Tyr Gly Ala Ala Arg
450 455 460
Asp Asp Ala Gly Arg Val Gly Asp Asp Lys Asp Ser Ser Asp Asp Asp
465 470 475 480
Val Asn Thr Ser Arg Lys Ala Lys Ser Thr Ser Thr Thr Thr Lys Asp
485 490 495
Ala Ser Ser Thr His Cys Tyr Ser Ser Cys Ala Ser Val Asp Thr Gly
500 505 510
Lys Val Val Val Ser Ser Ser Asn Val Gly Ser Asp Cys Val Gly Arg
515 520 525
Lys Ser Ser Asn Lys Ser His Thr Asp Val Val Asp Ser Ser Ser Lys
530 535 540
His Arg Asp Asn Ser Cys Lys Lys Gly Asp Cys Ala Asn Thr Ser Ser
545 550 555 560
Lys Arg His Ser Thr Asp Val Gly Lys Gly Asp Asn Cys Ala Gly Met
565 570 575
Ser Ser Asp Asp Asp Cys Asp Ser Arg Thr Asn Lys Ser Gly Val Val
580 585 590
Asp Ser Val Tyr Asp Gly Val Ala Tyr Ala Asn Arg Asp Asp Thr Ser
595 600 605
Thr Asn Ala Ser Thr Lys Lys Val His Ala Ser Thr Ala Asn Arg Thr
610 615 620
Lys Asp Ala Asn Thr Ser Ala Val Ser Met Trp Arg Thr Ala Asn Thr
625 630 635 640
Asn Ala Ser Ser Ser Ala Ser Lys Asp Trp Arg Val Ser Ser Gly Lys
645 650 655
Ser Thr Arg Arg Lys Lys Arg Arg Arg Gly Asp Cys Ser Ser Ala Val
660 665 670
Lys Asn Asn Gly Ala Lys Thr Asp His Arg Ser Arg Ser Arg Ser Val
675 680 685
Lys Asn Arg Gly Lys Lys Lys Arg Ala Asp Asn Asn Ala Arg Ala Ala
690 695 700
Val Ser Ser Ser Met Ser Val Asp Asn Val Asp Thr Ser Asp Ser Asp
705 710 715 720
Ser Asp Asp Gly Thr Met Thr Ala Asn Thr Ala Cys Ala Lys Val Asp
725 730 735
Met Met Ala Val Tyr Arg Arg Ser Ser Ser Ala Arg Arg Asp Val Ala
740 745 750
Ala Ser Ser Ser Tyr Ser Ser Gly Lys Thr Asn Ser Arg Ser Asp Ser
755 760 765
Asp Lys Ser Ser Ser Arg Thr Thr Thr Asn Asn Ser Asn Lys Asp Ala
770 775 780
Val Ala Thr Gly Asp Val Ala Ser Thr Asp Ser Arg Lys Arg Lys Ser
785 790 795 800
Cys Asn Ser Ala Asn Val Val Asn Asn Lys Ala His Ala Ala Thr Lys
805 810 815
Ser His Gly Arg Ser Asn Ala Gly Ala Ser Tyr Lys Asp Asp Asp Asp
820 825 830
Asp Ala Tyr Ala Thr Asp Asp Ala Met Ala His Ala Thr Ser Lys Arg
835 840 845
Ser Thr Lys Thr Lys Asp Ala Ser Val Lys His Gly Asn Arg Asn Asp
850 855 860
Gly Lys Asp Gly Ser Asp Gly Trp
865 870
<210> 12
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
tgtcccagga ttagaatgat taggc 25
<210> 13
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
agccctcttc tttcgatcca tcaac 25
<210> 14
<211> 25
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
ttaatccaaa ctactgcagc ctgac 25
<210> 15
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
tgcaggagat tttctccaac ga 22
<210> 16
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
agccttcgta atctcggtgt tca 23
<210> 17
<211> 26
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
ggtaccatgg gacccgagtt tccgat 26
<210> 18
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 18
ctgaaaaatg gcatccaaca ag 22
Claims (9)
1. The application of the gene BnaFANCM in male sterile breeding of rape is editing the BnaFANCM gene; the edit type is that insertion of a T base results in a frameshift mutation in the gene.
2. A gene editing vector pKSE 401-binafancm-CRISPR, the gene editing vector comprising a binafancm gene sequence and a binafancm gene edited CRISPR/Cas9 system sequence element set comprising U6-26p-Target1-gRNA, U6-26p-Target2-gRNA and a Cas9 gene optimized according to codons and a resistance gene Kana;
the nucleotide sequence of Target1 is shown as SEQ.ID.NO. 1; the nucleotide sequence of Target2 is shown as SEQ ID No. 2; the nucleotide sequence of sgRNA is shown as SEQ.ID.NO. 3.
3. A genetically engineered bacterium for site-directed mutagenesis of the bnafacm gene, the genetically engineered bacterium comprising the gene editing vector pKSE 401-bnafacm-CRISPR of claim 2, the host bacterium of the genetically engineered bacterium being agrobacterium GV3101.
4. A method for obtaining male sterile mutants of brassica napus, which is characterized in that the method utilizes a CRISPR/Cas9 system to edit the BnaFANCM gene of brassica napus; the edit type is that insertion of a T base results in a frameshift mutation in the gene.
5. The method according to claim 4, characterized in that the method comprises:
(1) Designing and screening sgRNA targets Target1 and Target2 aiming at BnaFANCM gene sequences, wherein the nucleotide sequence of Target1 is shown as SEQ ID No.1, the nucleotide sequence of Target2 is shown as SEQ ID No.2, and synthesizing primers required for constructing a vector;
(2) Constructing a double-target CRISPR/Cas9 gene editing vector pKSE401-BnaFANCM-CRISPR;
(3) Extracting plasmid, transforming host bacteria to obtain genetically engineered bacteria containing gene editing expression vector pKSE401-BnaFANCM-CRISPR;
(4) The pKSE401-BnaFANCM-CRISPR vector is transferred into a receptor material by using an agrobacterium-mediated transformation mode to obtain a transgenic plant.
6. The method of claim 5, wherein the primer sequence in step (1) is as follows:
DT1-BsF(SEQ.ID.NO.4):
ATATATGGTCTCGATTGAGTCCACACGAATTACTTAGTT
DT2-BsR(SEQ.ID.NO.5):
ATTATTGGTCTCGAAACGCTGAACTTTTTGCGACTGCAA
DT1-F0(SEQ.ID.NO.6):
TGAGTCCACACGAATTACTTAGTTTTAGAGCTAGAAATAGC
DT2-R0(SEQ.ID.NO.7):
AACGCTGAACTTTTTGCGACTGCAATCTCTTAGTCGACTCTAC。
7. the method according to claim 5, wherein the BnaFANCM gene comprises BnaFANCM-C05 and BnaFANCM-A05, the nucleotide sequence of the sgRNA is shown in SEQ ID No.3, and the Target1 and the Target2 are common targets of the BnaFANCM-C05 and the BnaFANCM-A05.
8. The method of claim 5, wherein the host bacterium in step (3) is agrobacterium GV3101.
9. The method of claim 5, wherein the acceptor material in step (4) is Y127.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210631019.0A CN115011609B (en) | 2022-06-06 | 2022-06-06 | BnaFANCM gene, application and method for obtaining male sterile mutant of rape |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210631019.0A CN115011609B (en) | 2022-06-06 | 2022-06-06 | BnaFANCM gene, application and method for obtaining male sterile mutant of rape |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115011609A CN115011609A (en) | 2022-09-06 |
CN115011609B true CN115011609B (en) | 2024-03-19 |
Family
ID=83073087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210631019.0A Active CN115011609B (en) | 2022-06-06 | 2022-06-06 | BnaFANCM gene, application and method for obtaining male sterile mutant of rape |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115011609B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104411158A (en) * | 2012-06-29 | 2015-03-11 | 瑞克斯旺种苗集团公司 | Line design |
CA2947506A1 (en) * | 2014-05-30 | 2015-12-03 | Institut National De La Recherche Agronomique | Increase in meiotic recombination in plants by inhibiting an recq4 or top3a protein of the rtr complex |
CN111344407A (en) * | 2017-09-15 | 2020-06-26 | 联邦科学技术研究组织 | RNA molecules |
CN112888785A (en) * | 2018-08-03 | 2021-06-01 | 联邦科学技术研究组织 | RNA molecules comprising non-canonical base pairs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2980212A1 (en) * | 2011-09-16 | 2013-03-22 | Agronomique Inst Nat Rech | INCREASE IN MEIOTIC RECOMBINATION IN PLANTS BY INHIBITION OF FANCM PROTEIN |
-
2022
- 2022-06-06 CN CN202210631019.0A patent/CN115011609B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104411158A (en) * | 2012-06-29 | 2015-03-11 | 瑞克斯旺种苗集团公司 | Line design |
CA2947506A1 (en) * | 2014-05-30 | 2015-12-03 | Institut National De La Recherche Agronomique | Increase in meiotic recombination in plants by inhibiting an recq4 or top3a protein of the rtr complex |
CN111344407A (en) * | 2017-09-15 | 2020-06-26 | 联邦科学技术研究组织 | RNA molecules |
CN112888785A (en) * | 2018-08-03 | 2021-06-01 | 联邦科学技术研究组织 | RNA molecules comprising non-canonical base pairs |
Non-Patent Citations (1)
Title |
---|
FANCM Limits Meiotic Crossovers in Brassica Crops;Aurélien Blary 等;《Frontiers in Plant Science》;第9卷;摘要、第10页右栏倒数第2段 * |
Also Published As
Publication number | Publication date |
---|---|
CN115011609A (en) | 2022-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004506427A (en) | Method for stable transformation of plants | |
CN110257421B (en) | Construction method and application of brassica napus gene mutant PTG8 | |
JP2002533090A (en) | Plant transformation method | |
CN109112146B (en) | Cloning and breeding application of gene qSLWA9 for controlling pod length and grain weight traits of brassica napus | |
CN112538492B (en) | SpCas9n variant capable of recognizing NRTH (Polyacrylamide) as PAM (Polyacrylamide) sequence and corresponding base editing system | |
CN112522302B (en) | Rice bidirectional single-base edited co-transcription unit gene ABE-CBE system and application thereof | |
CN113583099B (en) | Method for cultivating alfalfa male sterile line and corresponding maintainer line and related biological material thereof | |
CN116769792B (en) | Phyllostachys pubescens stem elongation related gene PheLBD12 and application thereof | |
CN113265403A (en) | Soybean Dt1 gene editing site and application thereof | |
CN115011609B (en) | BnaFANCM gene, application and method for obtaining male sterile mutant of rape | |
CN111690679B (en) | Recombinant expression vector for cultivating cucumber male sterile line and construction method and application thereof | |
CN116064568A (en) | Alfalfa MsASG166 gene and application thereof in improving drought tolerance of plants | |
CN114958867A (en) | Corn ear grain weight and yield regulation gene KWE2, and encoding protein, functional marker, expression vector and application thereof | |
CN114181965A (en) | Nucleic acid molecule, vector, cell and primer, application thereof and plant high-purity clone seed sorting method based on dual regulation | |
CN116121278B (en) | Phosphorylation mutation of CsRBOH5 and application thereof in improving citrus canker resistance | |
CN114231556B (en) | Application of GmECT2 in regulating plant height | |
CN114958866B (en) | Gene for regulating soybean branch number and application thereof | |
CN115976064B (en) | CsRBOH5 mutant gene for regulating and controlling citrus canker resistance, expression vector and application | |
CN113136388B (en) | Application of rice OsMAPKKK5 gene in aspect of improving plant height and grain type of rice | |
CN112080481B (en) | Spike-type related gene OsFRS5 and application and phenotype recovery method thereof | |
CN109097388B (en) | Application of GmCOP1a and/or GmCOP1b in plant height regulation | |
CN112813076B (en) | sgRNA composition for knocking out cotton GhTSTs gene and application of sgRNA composition in creating cotton short-fiber-free mutant | |
CN112575014B (en) | Base editor SpCas9-LjCDAL1 and construction and application thereof | |
CN110922459B (en) | Application of SlSNAT1 protein and related biological material thereof in regulation and control of plant seed aging resistance | |
CN118652906A (en) | Cloning and application of gene for regulating size of soybean seeds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |